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7ABSTRACT
Purpose: To investigate effects of segmental ileal and entire jejunoileal autotransplantation
(autotx) on body weight gain and small bowel morphology in growing pigs. Materials and
methods: At the first stage (I–III), weight gain was monitored and histomorphometric studies
of the small bowel were performed after small bowel transection, 75% proximal resection and
ileal remnant autotx. In addition, immunohistochemical analysis of crypt cell proliferation and
ileal enteroendocrine cell expression, and brush border disaccharidase activity measurements
according to the method of Dahlqvist were performed. Up to 14 week follow-up period was
used. In the second stage (IV, unpublished), the effects of jejunoileal denervation and in situ
autotx on the weight gain and small bowel morphology were studied and compared with the
laparotomy and transection controls eight weeks postoperatively. In addition, the effect of
growth hormone (GH) therapy after jejunoileal autotx was analyzed. Results: The percentage
weight gain in the transection, resection and resection + autotx groups of the first stage was
453 ± 28%, 309 ± 17% and 124 ± 15% (p < 0.05 in all comparisons), respectively (I–III). The
length of the remaining ileum increased significantly after resection (I), but remained
unchanged after ileal remnant autotx (II). Resection increased small bowel diameter and
weight, mucosal weight, villus height, villus surface area, and crypt depth (I). These adaptive
changes were suppressed after ileal remnant autotx (II). The number of proliferative crypt cells
increased after resection compared with transection (I), but decreased after ileal autotx
compared with resection (II). Specific activities of maltase and sucrase decreased in the mid-
ileum after resection indicating enterocyte immaturity, but the morphologic adaptation
compensated this defect (I). Ileal enteroendocrine cell expression remained unchanged after
small bowel resection. In contrast, total and proportional enteroendocrine cell counts decreased,
and enteroendocrine cell subtype distribution changed after ileal autotx (III). In the second
stage studies, the percentage weight gain of the laparotomy, transection, denervation and autotx
groups were 207 ± 6%, 209 ± 8%, 176 ± 10%, 172 ± 1%, respectively (p < 0.05 in denervation
and autotx vs. laparotomy and transection; IV). GH therapy significantly enhanced body weight
gain after jejunoileal autotx (191 ± 3% in GH + autotx group). Altogether, the jejunoileal
denervation and autotx with or without GH had only minor effects on the small bowel
morphology, and no effect on the crypt cell proliferation or enterocyte ultrastructure and
disaccharidase activities. Unexpectedly, ileal villi enlarged after jejunoileal denervation and
autotx (IV, unpublished data). Conclusion: Malnutrition may explain the poor small bowel
adaptation after segmental ileal autotx. However, impaired trophic hormone expression due to
changes in the ileal enteroendocrine cell number and distribution may also be involved.
Reduced weight gain and unaltered overall small bowel structure after jejunoileal denervation
and autotx suggest that neural isolation of the small bowel may cause enterocyte damage,
which impairs nutrient absorption. Administration of GH enhances body weight gain after
jejunoileal autotx in pigs, but the underlying mechanism remains unknown.
8INTRODUCTION
In intestinal failure the small bowel function is insufficient to maintain normal nutritional
balance. The most common etiology for intestinal failure is short bowel syndrome (SBS),
caused by a massive small bowel resection. The primary treatment for SBS is parenteral
nutrition (PN). Unfortunately, some patients with SBS will remain permanently depended on
PN, and thus at risk for developing life-threatening PN-related complications. Several different
surgical approaches to enhance the small bowel function of patients with SBS have been
developed (Shanbhogue and Molenaar 1994). In addition, the mechanisms that are responsible
for the small bowel growth regulation and postresectional adaptation have been intensively
examined. Understanding these phenomena would ultimately offer physicians powerful tools to
improve postresectional small bowel adaptation as a treatment for SBS. Currently, many details
of the regulation of the small bowel adaptation are known. Several hormones, growth factors,
and nutritional and other intraluminal factors are involved in the regulation of the small bowel
growth and the postresectional adaptation at least in experimental animals. Treatment with
various small bowel adaptation enhancers, such as glucagon-like peptide-2 (Jeppesen et al.
2001), or combination of growth hormone and glutamine with or without high carbohydrate
diet (Byrne et al. 1995, Scolapio et al. 1997, Szkudlarek et al. 2000), have been tried in order
to improve nutrient absorption of patients with SBS. However, at the present day, none of these
adaptation-modulating substances are routinely used as treatment for SBS.
Before the introduction of the PN therapy a complete gut failure was usually lethal. Thus, in
order to find a treatment for the patients with SBS in pre-PN era, methods of small bowel
transplantation were developed. Lillehei and colleagues published the first successful model of
small bowel autotransplantation in dogs in 1959. First attempts of small bowel transplantation
in humans were performed between 1964 and 1970. Unfortunately, these trials failed, mainly
due to technical reasons and graft rejection (Kirkman 1984). The survival and the quality of life
of patients with intestinal failure and SBS have significantly increased due to the improvements
in home PN therapy programs. At the same time, the need for small bowel transplantation has
decreased from the earlier days when no other treatment was available. However, some patients
may not manage with PN, or may develop life-threatening PN-related complications such as
liver dysfunction. These patients are considered as candidates for small bowel transplantation
(Grant 1999).
Grant and colleagues (1990) published the first case report of successful small bowel
transplantation in humans using cyclosporine as a primary immunosuppressive agent. The
outcome of small bowel transplantation has further improved after the introduction of
tacrolimus based immunosuppression (Todo et al. 1992). However, the immunologic and
immunosuppression-related complications together with unfavorable transplant function
9remain the major obstacles for the success of clinical small bowel transplantation (Grant 1999).
Currently, the number of human small bowel transplantations is more than 450 worldwide.
However, none of the clinical small bowel transplantations has been performed in Finland.
Most experimental studies concerning small bowel transplantation are focused on investigating
the graft function or underlying immunologic phenomena. Detailed morphologic studies
concerning other than rejection-related alterations of small bowel transplants are sparse. In the
studies presented in this thesis, weight gain was monitored and a detailed morphometric
analyses including changes in the crypt cell proliferation and expression of enteroendocrine
cells, and the measurement of brush border disaccharidase activities of the remaining small
bowel after adaptation to 75% proximal small bowel resection were performed in juvenile pigs.
By using these results as reference values the effect of ileal remnant autotransplantation on
body weight gain and postresectional small bowel adaptation was analyzed. Furthermore,
weight gain and morphologic changes of the small bowel structure and enterocyte maturation
after denervation of the entire jejunoileum, with or without ischemia and reperfusion, were
characterized in a porcine model. In addition, previously unpublished preliminary results of the
effects of systemic growth hormone (GH) therapy on the animal weight gain and small bowel
structure after jejunoileal autotransplantation are presented.
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REVIEW OF THE LITERATURE
SHORT BOWEL SYNDROME
Description and Etiology
Short bowel syndrome (SBS) is a condition characterized by various signs and symptoms,
especially diarrhea, malnutrition and weight loss that follow massive small bowel resection.
The mean post mortem length of small bowel is 275 cm in newborn infant and 575 cm in 20-
year olds (Weaver et al. 1991). Remnant small bowel length less than 150–180 cm in adults
(Messing et al. 1999, Thompson and Langnas 1999) and less than 75–100 cm in infants
(Wilmore 1972, Weber et al. 1991) has been used as a criterion for SBS. Thus, a significant
amount of small bowel may be resected without jeopardizing the patient’s nutritional
independence. However, the above mentioned values are not accurate since the length of the
remaining small bowel alone can not define SBS. The term intestinal failure has been used to
describe all the conditions, including SBS and other diseases such as motility disorders caused
by agangliosis or chronic intestinal pseudo-obstruction, in which the small bowel function is
insufficient to maintain normal nutritional balance (Jeppesen and Mortensen 2000).
Common causes for massive small bowel resection leading to SBS in adults are mesenteric
thrombosis, Crohn’s disease, abdominal trauma, radiation enteropathy, small bowel volvulus
and tumors (Booth and Lander 1998, Messing et al. 1999). Necrotizing enterocolitis and
intestinal anomalies such as atresia, malrotation with volvulus, and gastroscihis, are the main
underlying conditions leading to SBS in neonates. In addition, less frequent causes such as
intussusception, vascular malformations, and meconium peritonitis may lead to SBS in
pediatric patients (Goulet et al. 1991, Sondheimer et al. 1998).
Symptoms and Treatment
Symptoms
The main symptoms of SBS are diarrhea, malnutrition due to insufficient absorption of all
macronutrients, and weight loss. In addition, serious disturbances of water and electrolyte
balance, and deficiencies of fat-soluble vitamins and minerals may take place after massive
small bowel resection (McIntyre 1985). These absorption deficiencies are mainly a result of
diminished absorptive surface area after massive small bowel resection, but alterations in
digestion and in the enteral environment such as bacterial overgrowth may also be involved.
The severity of the symptoms of SBS depends on the site and length of the small bowel
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resection. In general, a longer small bowel resection leads to more severe symptoms. On the
other hand, even a short resection of distal ileum can produce SBS related symptoms due to the
loss of specialized areas responsible for bile acid and B12-vitamin absorption and production of
small bowel adaptation and motility modulating L-cell derived peptide hormones (Figure 1). In
addition, resection of colon and ileocecal junction usually worsens the symptoms of SBS
(Weser 1976, Spiller et al. 1988, Green et al. 1989, Jeppesen et al. 1999).
FIGURE 1. Portion of the gastrointestinal track, small bowel structures are typed in bold. The most
important differences of the jejunum and ileum affecting the symptoms of SBS are listed.
Medical and non-transplantation surgical treatment
Total parenteral nutrition (TPN) is usually inevitable immediately after massive small bowel
resection. This phase usually takes few days/weeks depending on the magnitude of the
resection and postoperative course of the patient. However, enteral nutrition should be
introduced as soon as possible to optimize the adaptive response (Sturm et al. 1997, Booth and
Lander 1998). Medication is used to increase nutrient absorption, to ease the symptoms and to
avoid SBS-related complications (Table 1). Several non-transplantation surgical procedures
intended to increase absorptive surface area, prolong intestinal transit time or improve motility
of the remaining small bowel have been developed (Shanbhogue and Molenaar 1994). Many of
these procedures are not yet clinically feasible. However, intestinal tapering and lengthening,
and segmental reversal of the small bowel may have beneficial effects for selected patients with
SBS (Thompson et al. 1995, Panis et al. 1997).
Esophagus
Stomach
Ligament of Treitz
Duodenum
Jejunum (2/5 of jejunoileal length)
- Absorbs most nutrients, but no bile
        acids and B12-vitamin
- Contains less L-cells than ileum
Ileum (3/5 of jejunoileal length)
- Absorbs bile acids and B12-vitamin
- Contains most of the L-cells
- Great adaptive ability
Colon
Cecum
Ileocecal junction
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TABLE 1. Medication used or tried as treatment for patients with SBS
Medication Indication or action
Proton pump inhibitors or H2-blockers Gastric acid hypersecretion due to hypergastrinemia
Loperamide Severe diarrhea
Cholestyramine Diarrhea caused by intracolonic bile acids due to ileal dysfunction
Cisapride Motility disorders
Octreotide Reduces excessive fluid and electrolyte losses
Antibiotics and probiotics Bacterial overgrowth
Cholylsarcosine May enhance fat absorption
References: O’Keefe et al. 1994, Booth and Lander 1998, Vanderhoof et al. 1998, Heydorn et al. 1999.
Prognostic Aspects
Over 90% survival rates have been reported in pediatric patients with SBS (Goulet et al. 1991,
Georgeson and Breaux 1992). In adults with SBS due to non-malignant cause, the 1, 2, and 5
year survivals have been reported to be 94%, 86% and 75%, respectively (Messing et al. 1999).
These high survival rates are largely a consequence of progress in PN treatment. However, PN
is associated with relatively high morbidity, mostly due to catheter-related septic problems and
PN-related hepatobiliary complications (Burnes et al. 1992, Quigley et al. 1993). Fortunately,
in many cases of SBS the need for PN is transient due to the adaptive ability of the small bowel
remnant. According to Messing et al. (1999) there is a 45% percent probability of PN
dependence in adult patients with SBS five years after onset of the disease. In most cases the
clinical adaptation is reached during the first two years after onset of SBS. Similarly, more than
half of the pediatric patients with SBS are successfully weaned off PN (Georgeson and Breaux
1992, Sondheimer et al. 1998). The remnant small bowel length seems to be the most
important factor determining the possibility of full nutritional independence. The length of the
remaining small bowel more than 30–35 cm with intact ileocecal valve, 60–65 cm with
jejunocolic anastomosis and 100–115 cm without colon are good prognostic factors when
evaluating adult patients’ possibility to eventually manage without PN support (Carbonnel et
al. 1996, Messing et al. 1999).
POSTRESECTIONAL SMALL BOWEL ADAPTATION
Morphologic Adaptation
The small bowel of rats and mice adapts after resection by macroscopic enlargement (dilatation
and probably lengthening), and by increasing crypt depth, villus height, and epithelial cell
density. These adaptive changes elevate mucosal and bowel weight/unit length, and increase
mucosal protein- and DNA-content. This enlargement of the existing structures increases
absorptive surface area of the remaining small bowel, although the density of villi and crypts
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may remain constant or even decrease. The muscular layer may also grow during the
adaptation, which together with the mucosal changes thickens the small bowel wall (Hanson et
al. 1977a, Williamson 1978, Helmrath et al. 1996). The overall ultrastructure of enterocytes
remains unaltered after small bowel resection in rats. However, microvillus surface area of
individual villous enterocytes may either decrease or increase during the adaptation after
resection (Zeitz et al. 1985, Schulzke et al. 1992).
In most studies with rabbits, dogs and pigs, the morphologic small bowel adaptation has been
similar to that in rodents (Swaniker et al. 1995, Nguyen et al. 1996, Thompson et al. 1999a,
Heemskerk et al. 1999). Dilatation and elongation of the remaining small bowel after massive
resection have also been observed in patients with SBS, indicating that morphologic small
bowel adaptation occurs in humans (Thompson et al. 1995, Uen et al. 1999). In addition,
villous enterocyte hyperplasia is reported as an adaptive change after small bowel resection in
humans. However, villous hypertrophy, the main postresectional adaptive alteration in
experimental animals, has not been observed in patients with SBS (Porus 1965, O’Keefe et al.
1994).
The magnitude of the aforementioned postresectional adaptive changes of the small bowel
morphology depends of the extent and site of the resection. In general, the larger and the more
proximal the resection is, the greater are the adaptive changes (Hanson et al. 1977a, Dowling
1982, Thompson et al. 1999a). On the other hand, the most distal part of the terminal ileum
may remain morphologically unchanged after small bowel resection (Nguyen et al. 1996,
Thompson et al. 1996). This fact that proximal small bowel resection leads to greater adaptive
changes in the morphology of the distal small bowel remnant than vice versa may explain the
lack of villus hypertrophy after distal small bowel resection in humans (Porus 1965, O’Keefe et
al. 1994).
Mechanisms of the Structural Adaptation
Most studies concerning mechanisms and phenomena of the postresectional small bowel
adaptation are focused on examining the changes of the mucosa, although other layers of the
small bowel wall, especially the muscular layer also go through adaptive changes (Nguyen et
al. 1996). The morphologic adaptation of the small bowel mucosa is often considered a
consequence of the changes in the balance between crypt cell proliferation and enterocyte
apoptosis. However, several in vitro studies have demonstrated that communication of
epithelial cells with extracellular matrix and fibroblasts of the mesenchyme is also involved
with the regulation of the small bowel epithelial cell proliferation and differentiation (Carroll et
al. 1988, Kedinger et al. 1988). These interactions between epithelial cells and mesenchymal
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tissues are at least partly mediated via paracrine actions of fibroblast derived growth factors
(Dignass et al. 1994).
Crypt Cell Proliferation
Enhanced crypt cell proliferation after massive small bowel resection in rats and mice is seen as
increased number of proliferative crypt cells. However, the proliferation index (the number of
proliferative crypt cells/total number of crypt cells) may either increase or remain unchanged
(Hanson et al. 1977a and 1977b, Helmrath et al. 1996). The onset and duration of the
proliferative response after small bowel resection may vary in different species. In mice, the
increase in the crypt cell proliferation is obvious only 12 hours after resection, suggesting that
adaptation begins almost immediately after resection (Helmrath et al. 1996). In rats, the
increase in the crypt cell proliferation also starts in first days after resection and reaches a
plateau in less than two weeks (Hanson et al. 1977b). However, the adaptive
histomorphometric changes in rat mucosa are observable only few weeks after resection and
reach their maximum at one month. Thus, the proliferative response of the crypt cells precedes
the morphologic small bowel adaptation. In larger animals, and presumably also in humans, it
may take more time than in rodents to reach a new balance in the crypt cell proliferation rate
and to achieve full postresectional small bowel adaptation (Dowling 1982).
The crypt cell proliferation and thus the postresectional small bowel adaptation are regulated by
many humoral and non-humoral factors (discussed in detail later) of which many may
accelerate the cell cycle of the dividing crypt cell directly via enterocyte receptors. Increased
intracellular polyamine production, due to regulation of the activity of the enzymes involved
with polyamine synthesis, seems to be an essential secondary phenomenon leading to the crypt
cell proliferation (Dowling 1992). On the other hand, some humoral factors such as
transforming growth factor β regulate the epithelial cell differentiation from the mitotically
active cells to non-dividing mature cells, and thus reduce the proliferation of the cells of the
small bowel mucosa (Halttunen et al. 1996).
Enterocyte Apoptosis
Apoptosis is another important mechanism controlling the epithelial cell number in the small
bowel mucosa (Hall et al. 1994). In mice, the augmented crypt cell proliferation after massive
small bowel resection is accompanied by the increase in the number of apoptotic cells
(Helmrath et al. 1998a, Falcone et al. 1999a). This seems rational since the unbalance between
proliferation and apoptosis would eventually lead to an uncontrolled increase in the enterocyte
number. On the other hand, enterotrophic factors such as epidermal growth factor (EGF) and
glucagon-like peptide-2 (GLP-2) may, in addition to increasing the crypt cell proliferation,
reduce enterocyte apoptosis and thus accelerate adaptive mucosal growth (Tsai et al. 1997,
Helmrath et al. 1998b). Thus, the changes in the rate of the enterocyte apoptosis are involved
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with the postresectional small bowel adaptation. However, details of this event in the regulation
of the mucosal growth after small bowel resection are still mostly unknown.
Functional Adaptation
Digestion and Absorption
Gradual improvement of in vivo nutrient absorption and in the absorption per unit length of the
small bowel occurs during the postresectional small bowel adaptation in humans and in
animals. However, the proximal small bowel does not adapt to perform the specialized
functions of the ileum, and thus bile acid and B12-vitamin absorption may be permanently
impaired after distal small bowel resection. (Williamson 1978, Dowling 1982). The nutrient
uptake ability of the individual enterocytes may at least transiently be impaired (Sarac et al.
1996, Whang et al. 1996). In addition, the specific disaccharidase activities (U/g of mucosal
protein) may reduce after small bowel resection at least in rats (Weser and Hernandez 1971).
However, due to greater number of enterocytes after adaptation, the total disaccharidase activity
per unit length of the remaining small bowel may increase (Koruda et al. 1988). Thus, these
findings suggest that the postresectional enterocytes may be functionally immature. The
underlying reason for this enterocyte immaturity is not completely solved, but it seems to be
related to the increased crypt cell proliferation and diminished life-span of individual cells.
However, not all studies support this conclusion (Chaves et al. 1987). Nevertheless, the
increased small bowel surface area per unit length of the bowel together with the increased total
length of the remaining bowel mainly explain the improvement in the nutrient digestion and
absorption during the adaptation to small bowel resection.
Motility
Massive small bowel resection accelerates small bowel transit. The main underlying reason for
this is the shortened bowel length, but alterations in the motility patterns may also be involved.
Normal motor activity of the small bowel can be divided into the fasting and postprandial
states. The small bowel motility of the fasting state is characterized by migrating myoelectrical
complexes (MMC), while in the postprandial stage these organized motility complexes are not
seen (Otterson and Sarr 1993). Lengthening of the postprandial periods, reduced MMC
frequency, and impaired MMC propagation through the intestinal remnant in the acute phase
after massive distal small bowel resection have been reported in dogs (Uchiyama et al. 1996).
These changes had a tendency to normalize during the follow-up, but the motility patterns were
still abnormal 8 to 13 months after resection. Whether these changes are related to the a gradual
slowing in the small bowel transit after small bowel resection seen in dogs is unknown
(Quigley and Thompson 1993). However, it seems that the motility of the remnant small bowel
in dogs may adapt to maximize the time for the nutrient absorption. In contrast, the motility of
the postresectional small bowel remnant in humans has been reported to be accelerated in a
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way that may impair nutrient absorption (Schmidt et al. 1996). The proximal gut motility is
inhibited by a negative feedback mechanism, which is most likely mediated by ileal and colonic
L-cell derived peptide YY (Spiller et al. 1988, Nightingale et al. 1996). Thus, the loss of areas
responsible for peptide YY production may explain the acceleration of the proximal gut
motility after distal small bowel resection in humans.
Modulators of the Small Bowel Adaptation
Small bowel growth and postresectional adaptation are regulated by many different humoral
and non-humoral factors. Some of these adaptation enhancers are essential for the
postresectional small bowel adaptation under physiological conditions, and some may have a
role in the treatment of SBS. Many of the adaptation promoting substances mediate their effects
on the small bowel directly via enterocyte receptors. Other factors may have indirect adaptation
enhancing effects such as a capability to increase the expression of the humoral adaptation
modulators.
Diet and Pancreaticobiliary Secretions
Enteral nutrition and pancreaticobiliary secretes are essential intraluminal factors for the
postresectional small bowel adaptation (Levine et al. 1976, Al-Mukhtar et al. 1983). It is not
clear which components of the pancreaticobiliary fluid are responsible for the intestinotrophic
effects, but it seems that both bile and pancreatic juice are needed for normal adaptive response
(Williamson et al. 1978). In addition, various components of the food may differently enhance
small bowel adaptation after resection. Studies in rats show that dietary short-chain fatty acids
(SCFA) are important regulators of the postresectional small bowel adaptation (Kripke et al.
1991). Similarly, long-chain fatty acids, especially the polyunsaturated forms are able to
increase postresectional small bowel adaptive response in rats (Chen et al. 1995, Kollman et al.
1999). Further, free fatty acids in diet may induce greater adaptive stimulus than triglyserides
(Grey et al. 1984).
Colonic bacteria ferment unabsorbed carbohydrates into SCFAs, which are then absorbed by
the colon (Nordgaard et al. 1994). Pectin is a water-soluble fiber that is completely fermented
into SCFAs. Feeding this fiber to rats with intact small bowel, or after small bowel resection
has led to increased mucosal growth (Koruda et al. 1986, Andoh et al. 1999). Whether this
adaptation inducing ability of pectin is a result of colonic SCFA production or a direct effect of
pectin is unknown.
Dietary polyamines have been proposed to be important growth regulators of the normal
intestinal mucosa (Löser et al. 1999). Thus, increasing polyamine or their precursor content in
food could be one approach to enhance the postresectional small bowel adaptation. Enteral
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supplementation of ornithine-α-ketoglutarate, an important source of polyamine precursor
ornithine, increases small bowel polyamine synthesis and augments adaptive growth of villi in
rats after small bowel resection (Czernichow et al. 1997). Similarly, the amino acids glutamine
and arginine may be important modulators of small bowel adaptation. However, the results
concerning the importance of dietary supplementation of these amino acids for the regulation of
the mucosal growth after small bowel resection have been controversial (Vanderhoof et al.
1992a, Tamada et al. 1993, Hebiguchi et al. 1997, Welters et al. 1999).
Glucagon-like peptide-2
Enteroglucagon, a heterogenous peptide consisting of glicentin and oxyntomodulin, belongs to
the intestinal L-cell proglucagon derived peptides together with glucagon-like peptide-1, GLP-
2, and several spacer peptides (Bell et al. 1983). Many experiments in rats have demonstrated
increased plasma levels of enteroglucagon associated with the postresectional small bowel
adaptive changes (Sagor et al. 1982, Al-Mukhtar et al. 1983, Bilchik et al. 1995). In mice,
GLP-2 treatment suppresses enterocyte apoptosis and increases crypt cell proliferation leading
to the small bowel growth (Drucker et al. 1996, Tsai et al. 1997). These enterotrophic effects of
GLP-2 are demonstrated also in rats (Kato et al. 1999). Thus, retrospectively it seems obvious
that the actual adaptation-mediating factor in the previous studies in rats is GLP-2 expressed
together with enteroglucagon and other proglucagon-derived peptides.
GLP-2 may be a mediator of the trophic effects of many different small bowel adaptation
enhancers. For instance, the enterotrophic effects of enteral nutrients and pancreaticobiliary
fluids may at least partially be mediated via increased proglucagon-derived peptide expression
(Al-Mukhtar et al. 1983, Sagor et al. 1983, Tappender et al. 1996, Andoh et al. 1999).
Similarly, administration of neurotensin enhances and somatostatin inhibits normal
postresectional small bowel adaptation in rats most likely by modulating proglucagon-derived
peptide and thus GLP-2 expression (Sagor et al. 1985, De Miguel et al. 1994). Thus, according
to current knowledge, GLP-2 seems to be one of the most important single hormonal factors
regulating the growth and adaptation of the small bowel mucosa. Further, GLP-2 treatment
enhances absorptive capacity and increases the adaptive growth of the remaining jejunum after
massive small bowel resection in rats, proposing that this hormone may have a therapeutic use
in the treatment of SBS (Scott et al. 1998).
Growth hormone
Growth hormone therapy improves body weight gain, increases crypt cell proliferation and
enhances postresectional adaptive growth of the remaining small bowel in rats (Shulman et al.
1992, Benhamou et al. 1994, Gomez de Segura et al. 1996). All studies have not confirmed the
morphologic adaptation-promoting effects of GH (Park and Vanderhoof 1996). However,
enhanced brush border disaccharidase activity in rats (Park and Vanderhoof 1996) and
increased amino acid uptake in rabbits (Iannoli et al. 1997), due to the postresectional GH
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therapy, suggest that GH may have beneficial effects on the enterocyte maturation and function
after small bowel resection.
Growth factors and Other Humoral Modulators of Small Bowel Adaptation
Alterations in the expression of insulin-like growth factor-I (IGF-I), IGF-binding proteins and
IGF-receptors take place after small bowel resection in rats, suggesting that IGF-I regulates
normal postresectional small bowel adaptation (MacDonald et al. 1993, Ziegler et al. 1998). In
addition, exogenous IGF-I shows additive effects on the functional and morphologic adaptation
after small bowel resection in rats (Vanderhoof et al. 1992b, Ziegler et al. 1998). Similarly,
epidermal growth factor (EGF) is associated with the regulation of the small bowel growth
(Thompson 1999). Furthermore, treatment with EGF increases postresectional small bowel
adaptation in mice, rats and rabbits (Chaet et al. 1994, Swaniker et al. 1996, Shin et al. 1998,
Hardin et al. 1999). In addition, EGF may improve the postresectional enterocyte maturation
(O’Loughlin et al. 1994, Swaniker et al. 1996, Dunn et al. 1997). Taken together,
aforementioned findings suggest that both IGF-I and EGF are important regulators of the small
bowel growth and they may have a role in the treatment of SBS.
Other humoral factors in experimental settings capable to enhance small bowel mucosal growth
and adaptation in rodents include transforming growth factor-α, hepatocyte growth factor,
interleukin-11, keratinocyte growth factor, and 16,16-dimethyl-prostaglandin-E2 (Vanderhoof
et al. 1988, Estivariz et al. 1998, Kato et al. 1998, Falcone et al. 2000, Alavi et al. 2000). The
physiological role of these factors in the postresectional small bowel adaptation is unclear.
Combinations of the Adaptation Enhancers
The great number of the aforementioned factors (Table 2) suggests that small bowel growth and
adaptation are most likely regulated by a complex network of different hormones and other
substances, each having synergistic effects on the small bowel adaptation process. In fact, some
experiments indicate additive effects after administration of various adaptation regulator
combinations such as glutamine with IGF-I and GLP-2 with IGF-I or GH on the adaptive small
bowel mucosal growth (Ziegler et al. 1996, Drucker et al. 1997).
TABLE 2. Summary of the factors suggested to have small bowel adaptation enhancing properties.
Dietary factors Hormones and growth factors Others
Enteral nutrition Glucagon like peptide-2 Pancreaticobiliary fluids
Short-chain fatty acids Growth hormone Prostaglandin-E2
Long-chain fatty acids Insulin like growth factor-I Interleukin-11
Free fatty acids Epidermal growth factor 
Pectin Transforming growth factor-α 
Ornithine-α-ketoglutarate Hepatocyte growth factor 
Glutamine Keratinocyte growth factor
Arginine
See text for references.
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Clinical Experience of the Modulation of the Postresectional Adaptation
Byrne and colleagues (1995) reported increased protein absorption and reduced TPN needs in
an open trial with SBS patients treated with a combination of GH, glutamine and high
carbohydrate/low fat diet. Similar results were not observed with diet modulation alone,
suggesting that colonic fermentation of carbohydrates into SCFAs may not explain all the
observed positive effects. These results proposed that combination of GH and glutamine
therapy together with died modulation could be used as a treatment for SBS. However, these
results were not confirmed in a randomized and placebo controlled trial in patients with SBS
(Scolapio et al. 1997). In addition, there was no effect of high dose GH therapy and glutamine
supplementation on nutrient absorption when patients with SBS were maintained on a regular
diet (Szkudlarek et al. 2000), which suggests that diet modulation may be the underlying
mechanism for the positive results in the previous studies. In addition, water retention after GH
treatment with or without additional glutamine may explain the body weight gain seen after
such treatments (Ellegård et al. 1997, Scolapio 1999). Thus, the combination therapy with GH,
glutamine and high carbohydrate diet may not have benefits for all patients with SBS.
Enhanced energy and nutrient absorption with a tendency for villus height and crypt depth
increase was recently reported after GLP-2 treatment in eight patients with SBS (Jeppesen et al.
2001). These results concerning the use of directly enterotrophic hormone as a treatment for
SBS are encouraging. However, further randomized and placebo controlled studies with GLP-2
treatment alone or in combination with other agents such as IGF-I or EGF are needed before
these humoral adaptation modulators can be routinely used as a treatment for the patients with
SBS.
SMALL BOWEL TRANSPLANTATION
Experimental Models
Different animal models of small bowel transplantation have been developed for various
investigation purposes. Small bowel allotransplantation models are used when the
investigations are focused on the transplantation-related immunologic phenomena. A segment
of jejunum or ileum, or the entire small bowel has been implanted in continuity to the
recipient’s intestinal track (orthotopic small bowel transplantation) or as an additional loop
with stomas at both ends (heterotopic small bowel transplantation) (Gruessner 1998). Rejection
and immunosuppression may alter the graft function, and thus the allotransplantation models
are not optimal when the investigations are focused on the functional aspects of the small
bowel transplant. Inbred rat strains are ideal for the studies of non-rejecting small bowel
transplantation (syngeneic transplantation, isograft) and thus widely used (Sigalet et al. 1996,
Winkelaar et al. 1997). In larger animals, models of small bowel autotransplantation, in which
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one animal serves as an organ donor and a recipient of the same graft, have been used to avoid
confounding effects of immunophenomena (Lillehei et al. 1959). In addition, models of
complete extrinsic denervation without interruption of the small bowel blood flow have been
used to study the effects of neural isolation on the small bowel function (Sarr et al. 1989).
Factors Altering the Small Bowel Graft Structure and Function
Immunological Phenomena
Rejection is the most important immunophenomenon after small bowel transplantation. Graft-
versus-host-disease and posttransplantation lymphoproliferative disease are other immunologic
events that often impair the small bowel graft survival and harm the life of the recipients (Abu-
Elmagd et al. 1998). Acute small bowel graft rejection is characterized by patchy mucosal
lesions that histologically demonstrate various degrees of inflammation of the lamina propria,
morphologic alterations of the enterocytes and enterocyte sloughing, cryptitis and villous
blunting. In addition, full thickness biopsies of the small bowel allografts in experimental
animals show that submucosal inflammation, edema, and fibrosis, muscular layer
inflammation, myocyte degeneration and myocytolysis, and blood vessel endothelial
proliferation also occur during acute small bowel rejection. Chronic small bowel rejection is
characterized by mesenteric fibrosis, endothelial and intimal thickening of the blood vessels,
alterations in the mesenteric lymph nodes, and thickening of the muscular layer. In addition,
mucosal damage may occur during the chronic small bowel graft rejection, but it may at least
partly be a secondary ischemic change due to blood vessel alterations (Kuusanmäki et al. 1994
and 1997, Lee et al. 1996, Sugitani et al. 1997). These acute or chronic rejection-related
changes may ultimately lead to complete necrosis and loss of function of the small bowel graft.
However, even histologically non-detectable rejection may worsen the small bowel graft
function, for instance, due to decrease in the expression of the brush border enzymes
(Teitelbaum et al. 1989).
Neural Isolation and Transection of the Lymphatics
The small bowel transplantation necessitates disconnection of the extrinsic and intrinsic neural
networks and transection of all lymphatic connections. Transection of the lymphatics during the
small bowel transplantation disturbs the lymph circulation of the small bowel, and thus may
impair graft function, especially fat absorption. However, the intestinal lymphatic pathways
have natural ability for rapid regeneration. In dogs the regeneration of the lymphatics is
complete in four weeks after small bowel transplantation (Kocandrle et al. 1966), and even
shorter time for it is needed in rats (Schier et al. 1991). Therefore, surgical reconstruction of
lymphatics is not usually performed during small bowel transplantation. However, beneficial
effects on weight gain, improved survival and reduced chronic rejection related alterations were
recently reported with rats after surgical reconstruction of the lymphatics of the small bowel
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allotransplant, proposing that transient lymphatic disconnection may have long lasting adverse
effects on the function of the small bowel graft (Kellersmann et al. 2000).
Disconnected extrinsic small bowel neurons regenerate along the arterial axis of the small
bowel graft, but this process may take months or years to be complete (Kiyochi et al. 1995,
Sugitani et al. 1998). However, despite the neural isolation the overall structure of the intrinsic
small bowel nervous network, including distribution of the peptidergic nerves, remains
virtually unaltered after transplantation in rats, pigs and humans (Malmfors et al. 1980,
Sugitani et al. 1994, Hirose et al. 1995). However, several studies in dogs have shown
alterations in the tissue and plasma expression of different gut neuroendocrine or
enteroendocrine peptides after neural isolation of the small bowel, which clearly demonstrates
the importance of intact extrinsic innervation in controlling the function of the intrinsic gut
neuroendocrine system (Evers et al. 1990, Nelson et al. 1993). These denervation-induced
changes in the gut hormonal functions may have multiple adverse effects on the small bowel
graft function.
Ischemia and Reperfusion
When the blood flow to an organ is cut off, the cells start to die due to lack of energy and
accumulation of toxic metabolites. However, in the adequately stored organ this process takes
hours, thus enabling transplantation. Paradoxically, when the blood supply is restored, further
damage to the organ may take place as a consequence of the cascade of cellular events
mediating so called reperfusion injury (Grace 1994). In the rat small bowel transplants, the
ischemia-reperfusion injury (IRI) causes mucosal hemorrhage, sloughing of the epithelium,
edema of the lamina propria, and leukocyte infiltration in the muscular layer (Müller et al.
1994, Hierholzer et al. 1999). However, although the mucosal IRI-related changes may initially
be severe, almost full recovery of these alterations occurs within few days postoperatively in
rats (Teitelbaum et al. 1989, Müller et al. 1994), and in one month in dogs (Takeyoshi et al.
2001).
Bacterial Overgrowth
The intestinal bacterial overgrowth alters the small bowel function, and it has been proposed as
a reason for the late onset absorptive impairment after small bowel transplantation (Thompson
et al. 1992). In experimental animals, the small bowel bacterial overgrowth has been observed
in the non-rejecting syngeneic or autologous small bowel transplantation models, suggesting
the underlying reason to be a component of the transplantation procedure per se (Browne et al.
1991, Thompson et al. 1992, Biffi et al. 1995). Inhibited bowel motility due to bowel wall
transection and complete neural isolation may at least partially explain the bacterial overgrowth
after small bowel transplantation (Sarr et al. 1989, Johnson et al. 1994 and 1995, Niewenhuijs
et al. 1998). However, other causes, such as immunological phenomena and
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immunosuppression, may additionally promote bacterial overgrowth after small bowel
allotransplantation (Lee et al. 1995).
Immunosuppression
Currently, the immunosuppression in clinical small bowel transplantation is based on
tacrolimus and corticosteroids. Some centers have used additional immunosuppressants
including azathioprine, cyclophosphamide, mycophenolate mofetil and OKT3 in their treatment
strategies (Asfar et al. 1996, Langnas et al. 1996, Abu-Elmagd et al. 1998, Goulet et al. 1999).
Proper immunosuppression is essential for maintenance of the small bowel allograft function.
On the other hand, as previously mentioned, immunosuppressive therapy may provoke bacterial
overgrowth and thus impair the function of the small bowel graft (Lee et al. 1995). In addition,
immunosuppression may lead to growth of opportunistic infectious organisms, of which
cytomegalovirus (CMV) may cause enteritis and thus worsen the small bowel graft function
(Asfar et al. 1996, Langnas et al. 1996). Along with the infectious problems,
immunosuppressants may directly alter gut function. For instance, cyclosporine inhibits
nutrient absorption in healthy rats (Sigalet et al. 1992). In addition, both cyclosporine and
tacrolimus have caused blood flow disturbances and reduced maltose absorption in rat small
bowel isografts (Greenstein et al. 1994, Sun et al. 1996).
Morphology and Function of the Non-rejecting Small Bowel Graft
Morphology
Only few studies concerning non-rejection-related morphologic chances after small bowel
transplantation have been published. The results of these studies have been controversial. In the
early work of Ballinger and colleagues (1962), the small bowel mucosa was reported to be
severely damaged three weeks after autotransplantation in dogs, and some shortening and
thickening of the villi was still seen at 22 weeks postoperatively. Similar changes were
observed after neural isolation and lymphatic disconnection without ischemia. In contrast, in
later studies the overall small bowel structure and the mucosal histomorphometric
characteristics have been normal after complete jejunoileal denervation in dogs (Ishii et al.
1993, Sarr et al. 1996). Similarly, soon after healing of possible IRI-related damages, the
overall morphology and mucosal histology of the non-rejecting orthotopic small bowel grafts
have been well preserved in different experimental animals (Teitelbaum et al. 1989, Thompson
et al. 1992, Ishii et al. 1993, Takeyoshi et al. 2001). Furthermore, a small bowel transplant may
not only retain normal structure, but it may also have an ability for structural adaptive growth
(Kimura et al. 1988, Kirsch et al. 1991, Rahman et al. 1996, Ferguson and Thompson 2000).
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Digestive Function
Activity of the brush border enzymes decreases after small bowel transplantation. However, in
rats the postoperatively decreased disaccharidase activities normalize in four days after
syngeneic small bowel transplantation (Teitelbaum et al. 1989). Similar tendency of recovery
of brush border enzyme activities is seen in pigs after small bowel autotransplantation (Akhtar
et al. 1996). In addition, neural isolation does not alter the specific activity of enterocyte brush
border disaccharidases in dogs (Sarr et al. 1996). Thus, after small bowel transplantation, the
underlying mechanism of the initial changes in the activity of the enterocyte brush border
enzymes is most likely a reversible IRI-related damage. High activity of brush border
disaccharidases observed in pediatric patients with non-rejecting small bowel transplant
supports this conclusion (Kaufman et al. 2000).
Absorptive Function
The results in experimental animals concerning the long-term absorptive function of the
denervated or transplanted small bowel are somewhat controversial. Raju et al. (1989) reported
immediate and long-term (12 months postoperatively) decrease in D-xylose and fat absorption
after small bowel autotransplantation in dogs, suggesting that either denervation or IRI may
diminish the long-term nutrient absorption ability of the small bowel graft. However, most of
the other studies have not confirmed these findings. Neural isolation of jejunoileum reduces
water, electrolyte, bile salt, and nutrient absorption in dogs. However, most of these changes
tend to normalize within the first two months (Herkes et al. 1994, Oishi and Sarr 1995, Oishi et
al. 1996, Foley et al. 1998), and no long-term abnormalities in the nutrient absorption occur
after complete small bowel neural isolation in dogs (Sarr et al. 1991). In addition, preserved fat
absorption in humans with fully functioning non-rejecting small bowel graft (Kaufman et al.
2000), and unchanged nutrient absorption after syngeneic small bowel transplantation in rats
(Sigalet et al. 1996, Winkelaar et al. 1997), indicate that the additional IRI-related changes
after small bowel transplantation may not alter the nutrient absorption in the long-run.
Motility of the Small Bowel Graft
Small bowel transection and subsequent bowel anastomosis disturbs the coordination of MMC
propagation between the proximal and distal ends of the transection site, alters the postprandial
motility patterns, and delays the intestinal transit (Johnson et al. 1995). In addition, a complete
neural isolation and IRI may cause changes of the neuromuscular system controlling the small
bowel motility. In the canine model of the small bowel denervation, the motility changes
related to small bowel transection are accompanied by inhibited or delayed onset and shorter
duration of the postprandial motility response (Sarr et al. 1989, Johnson et al. 1994).
Restoration of temporal coordination of the MMC propagation in 14 weeks after small bowel
denervation in dogs indicates that the transection or denervation-related chances in the fasting
motility patterns may at least partially be transient. However, the changes in the feeding
response of the small bowel motility after neural isolation may take longer time to recover than
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the fasting motility patterns, or they may be permanent (Sarr and Duenes 1990). In addition, IRI
may damage the intrinsic neural network, and thus delay recovery of denervation-related
changes in the fasting motility after small bowel transplantation (Quigley et al. 1990), although
all studies have not confirmed this suggestion (Nakada et al. 1994). Nevertheless, significantly
shortened small bowel transit time after small bowel autotransplantation suggests that the small
bowel denervation and IRI may together cause long lasting alterations in the small bowel
motility which may differ from the changes seen after small bowel denervation (Nakada et al.
1994).
Clinical Small Bowel Transplantation
Candidates for Small Bowel Transplantation
The current results of the survival and morbidity of patients on home PN are better than those
reported after small bowel transplantation. Therefore, isolated small bowel transplantation
should be considered only for those patients with permanent intestinal failure who do not
manage with TPN. These patients include those who have severely limited venous access, or
already have developed PN-related liver dysfunction and are at risk for having a liver failure.
Combined small bowel and liver transplantation should be offered for those patients who
already have PN-related liver failure or whose intestinal failure is caused by a state that can be
treated with liver transplantation. In addition, a surgical removal of most abdominal organs due
to a locally aggressive tumor may necessitate multivisceral transplantation of stomach,
pancreas, intestine and liver (Grant 1999).
The exact number of potential candidates for small bowel transplantation is hard to evaluate.
As previously mentioned, less than half of all patients with SBS remain permanently depended
on PN, and thus have an irreversible gut failure (Georgeson and Breaux 1992, Sondheimer et
al. 1998, Messing et al. 1999). Ingham Clark et al. (1992) have estimated that 12–40% of all
patients with irreversible gut failure would benefit from small bowel transplantation. With this
estimation approximately 6–20 adults in the United Kingdom could be treated with small
bowel transplantation annually. In Southern Finland approximately 1–2 patients/year/1.27
million population could benefit from small bowel transplantation (Pakarinen et al. 1995).
Clinical Experience and Current Status
First attempts of small bowel transplantation between 1964 and 1970 failed mainly due to
technical and immunological complications (Kirkman 1984). Advances in other solid organ
transplantations and introduction of powerful immunosuppressive agents raised the interest on
small bowel transplantation in the 1980s. The first successful small bowel transplantation in
human was published in 1990 by using cyclosporine as the primary immunosuppressive agent
(Grant et al. 1990). However, the overall survival results of small bowel transplantation have
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been significantly augmented by the use of tacrolimus based immunosuppression (Todo et al.
1992, Asfar et al. 1996).
Most of the clinical small bowel transplantations have been performed using small bowel grafts
or organ combinations (combined liver-small bowel or multivisceral graft) of ABO-blood
group identical and HLA-mismatching cadaver donors. Some centers have tested CMV status
of the donors and recipients. However, CMV positive grafts have been used for CMV negative
recipients (Asfar et al. 1996, Langnas et al. 1996, Abu-Elmagd et al. 1998, Goulet et al. 1999).
Chronic lack of suitable organs for the transplantation increases the waiting period for the
cadaver graft. As a solution, a model of small bowel transplantation using a partial small bowel
graft of a living related donor has been tried (Pollard 1997, Fujimoto et al. 2000). This latter
mode may have some benefits compared with the use of cadaveric grafts, the better tissue
matching and reduced cold ischemia time being the most important. However, surgical and
anesthesia-related risks for the donor are inevitable disadvantages of the small bowel
transplantation with living relative graft donors (Pollard 1997).
According to the latest report of International Intestinal Transplantation Registry altogether 446
patients have been treated with small bowel transplantation in 46 centers worldwide. Isolated
small bowel transplantation, combined liver-small bowel transplantation and multivisceral
transplantation have been performed 216, 186 and 72 times, respectively. More than half of all
small bowel transplant recipients have been children, mostly between one and 13 years of age.
The indications for the small bowel transplantation vary between pediatric and adult patients as
shown in Table 3.
TABLE 3. Indications for the small bowel transplantation in pediatric and adult patients*.
Pediatric patients Adult patients
Gastroschisis 22 % Intestinal ischemia 21 %
Volvulus 22 % Tumors 20 %
Necrotizing enterocolitis 12 % Crohn’s disease 16 %
Pseudo-obstruction 10 % Trauma 12 %
Intestinal atresia 9 % Familial polyposis 10 %
Aganglionosis 7 % Volvulus 9 %
Miscellaneous 19 % Miscellaneous 14 %
* Data gathered from the International Intestinal Transplantation Registry’s internet page,
(http://www.lhsc.on.ca/itr/, accessed on 30/01/01)
The number of small bowel transplantations performed each year has increased steadily during
the last decade, and the results of the graft and patient survival have improved. For isolated
small bowel transplantation performed after February 1995 the one year graft and patient
survivals have been 55% and 69%, respectively (Grant 1999). Similarly, the one year survival
of combined liver-small bowel and multivisceral grafts has been 63%. However, the long-term
graft and patient survivals are not completely satisfactory. The main reason for the small bowel
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graft loss has been rejection (in 68% of pediatric patients and in 42% of adults), followed by
graft vascular problems (including thrombosis, ischemia, bleeding), sepsis, lymphoproliferative
disease or lymphoma, multi-organ failure and other reasons. Forty-nine per cent of all patients
treated with small bowel transplantation have died. Sepsis (55%), non-transplant organ failure
(14%), posttransplant lymphoma (14%) and graft vascular problems (13%) have been the most
common reasons for mortality. Only 12% of deaths occurred due to rejection, which has been
the main cause for graft loss. In addition, although graft versus host disease is an important
cause for morbidity among small bowel graft recipients, it rarely leads to death of the patient or
to loss of the graft (Abu-Elmagd et al. 1998). Most of the survived small bowel transplant
recipients have achieved full graft function (76% of pediatric patients, 81% of adults),
indicating that small bowel transplantation can be used as an alternative treatment for selected
patients with irreversible intestinal failure. (Unless otherwise mentioned, the data of the above
paragraph was gathered from the International Intestinal Transplantation Registry’s internet
page (http://www.lhsc.on.ca/itr/, accessed on 30/01/01).
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AIMS OF THE STUDY
The main purpose of the studies presented in this thesis was to investigate the effects of
segmental ileal and entire jejunoileal transplantation on the body weight gain, and small bowel
morphology and adaptation in non-rejecting animal models of the small bowel transplantation.
In addition, therapeutic effects of GH after small bowel autotransplantation were investigated.
Porcine models of massive proximal small bowel resection, segmental ileal autotransplantation,
jejunoileal denervation, and in situ jejunoileal autotransplantation were used. The specific aims
were:
1. To examine weight gain and postresectional small bowel adaptation after 75% proximal
small bowel resection. These studies were performed in order to have reference values for
later studies with segmental ileal autotransplantation. The studied adaptive changes of the
small bowel included morphologic alterations, crypt cell proliferation, brush border
disaccharidase activities (I), and ileal enteroendocrine cell expression (III).
2. To evaluate the effects of the ileal remnant autotransplantation on the body weight gain and
postresectional small bowel adaptation (II, III).
3. To characterize the changes in the weight gain, and small bowel morphology, crypt cell
proliferation and enterocyte maturation after denervation and in situ autotransplantation of
the entire jejunoileum (IV).
4. To investigate the effect of GH on body weight gain and small bowel structure after in situ
jejunoileal autotransplantation (unpublished).
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MATERIALS AND METHODS
STUDY DESIGN
The studies presented in this thesis were performed in two separate stages (Table 4, Figure 2).
For the first stage, a porcine model of 75% proximal small bowel resection was created. With
this model, the body weight gain and the adaptive morphological and crypt cell proliferative
alterations, and the changes in the ileal enteroendocrine cell expression and brush border
disaccharidase activities of the small bowel remnant were analyzed (I, III). A model of
segmental (25% of total jejunoileal length) ileal autotransplantation was used for analyzing the
effect of the autotransplantation to the weight gain and postresectional small bowel adaptation
(II, III). Up to fourteen week follow-up period was used in these first stage studies. Additional
groups of four and eight weeks follow-up were used in study II to find out the timing of the
possible adaptive alterations in the small bowel after resection and postresectional ileal
autotransplantation.
Porcine models of denervation and in situ autotransplantation of the entire jejunoileum were
created for the second stage of the study (IV, unpublished). Sham laparotomy and small bowel
transection groups were used as controls. By using these models, the effects of different
components of the jejunoileal autotransplantation procedure to the weight gain, small bowel
morphology, and enterocyte ultrastructure and brush border disaccharidase activities were
studied (IV). In addition, the model of in situ jejunoileal autotransplantation was used to study
the effects of systemic GH therapy on the small bowel graft structure and the weight gain of the
animals (unpublished). Eight-week follow-up period was used in the second stage.
ETHICS AND ANIMAL CARE
Altogether 68 growing female pigs were finally included in these studies (Table 4). In the
second stage studies, several additional animals died at the operation or few days
postoperatively due to technical, anesthesia-related or unknown reasons. The experimental
animals received humane care according to the principles of Laboratory Animal Care and the
Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory
Animal Resources and published by the National Institute of Health (NIH publication no. 86–
23, revised 1985). An authorization (No. 154613) to perform these studies was given by the
Provincial Government of Uusimaa and Southern Finland in accordance with Finnish
legislation. The animals were housed individually in a light and temperature controlled
environment. During the first stage studies (I–III), the pigs were fed twice a day with standard
pig food (Suomen Rehu Ltd., Turku, Finland), which was freely available for one hour at
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standardized times. At the second stage studies (IV, unpublished), the animals were weighed
weekly and fed twice a day with a standardized amount (25 g/kg/day) of pig food. Water was
offered ad libitum. The animals were kept on a low residue liquid diet for the first
postoperative day and then standard pig food was introduced.
TABLE 4. Study groups and the number of animals used in the first and second stage studies
First stage groups (I–III) n Second stage groups (IV, unpublished data) n
Preoperative 5 Laparotomy 5
Transection 5 Transection 6
Resection 15 Denervation 6 (6)
Resection + Autotx 15 In situ jejunoileal Autotx 6 (9)
In situ jejunoileal Autotx + GH 5 (1)
Autotx = autotransplantation, GH = growth hormone. The number of additional animals lost during 
the studies is stated in parenthesis.
ANESTHESIA
General anesthesia was induced by a subcutaneous dose of ketamine (500–1000 mg) (Ketalar;
Parke-Davis Scandinavia AB, Solna, Sweden) mixed with azaperon (120–240 mg) (Stresnil;
Janssen-Cilag, Vienna, Austria), and maintained with 0.5–1% halothane (Trothane; ISC
Chemicals Ltd, UK) and oxygen inhalation under spontaneous ventilation with endotracheal
intubation. Intravenous dose of atropine (0.01 mg/kg) (Atropin; Leiras, Turku, Finland),
diazepam (3 mg) (Stesolid Novum; Kabi Pharmacia, Stocholm, Sweden) and, when needed,
additional doses of ketamine (up to 250-mg) and azaperon (up to 200-mg) were given before
intubation. Intramuscular dose of ceftriaxone (500-mg) (Rochephalin; Roche, Basel,
Switzerland) was used as anti-microbial prophylaxis. During the operations, 1000-ml Ringer’s
lactate was infused intravenously. A single 50-mg intramuscular dose of flunixin (Finadyne;
Orion-Farmos, Turku, Finland) was given for postoperative analgesia. In addition, during the
second stage studies (IV, unpublished), the animals were sedated two hours prior to the
induction of the general anesthesia with 30–60 mg midazolam (Dormicum; Roche, Espoo,
Finland) per os.
OPERATIONS
First Stage Operations
Five pigs were studied as preoperative controls in study I. In the resection group (n = 15; five
animals in four, eight and 14 week follow-up groups; I–III), the proximal 75% of small
intestine was resected from 10 cm distal to the Ligament of Treitz, and the ileum was
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transected 5 cm proximal to the ileocecal junction (Figure 2). Thus, the duodenum, 10 cm of
the proximal jejunum, and the distal 25% of the small bowel remained in situ. In the
transection group (n = 5) of the first stage studies (I, III) the small intestine was transected at
corresponding sites as in the resection group, but no resection was performed. An orthotopic
ileal autotransplantation (n = 15; five animals in four, eight and 14 week follow-up groups;
II, III) with simultaneous resection of the proximal small bowel was carried out with a
modification of the method described in detail by Pakarinen et al. (1996a). Briefly, the distal
25% of the small bowel was isolated on the vascular pedicle composed of the branches of the
superior mesenteric artery and the vein arising distal to the colonic branches. After the
mesentery of the ileum was freed, the superior mesenteric vessels were divided and the graft
was perfused through the artery with cold (+4 °C) heparinized (Heparin; Leiras, Turku,
Finland; 5000 IU) Ringer’s solution (1000 ml) until the venous effluent was clear. The
harvested small bowel was kept in cold isotonic saline solution, and a proximal 75% small
bowel resection was performed as described above. After systemic heparinization (Heparin;
Leiras; 3500 IU), the superior mesenteric vessels were anastomozed to the aorta and the
inferior vena cava below the renal vessels. The total ischemic time averaged 60 min. Bowel
continuity was restored by end-to-end anastomoses.
Second Stage Operations
In the transection group (n = 6) of the second stage studies (IV), the jejunum was transected
and reanastomozed end-to-end 5 cm distal to the Ligament of Treitz (Figure 2). Five animals
served as laparotomy controls. Extrinsic jejunoileal denervation (n = 6) with transection of
lymphatics was performed according to Sarr et al. (1989). The jejunoileum was transected 5 cm
distal to the Ligament of Treitz and 5 cm proximal to the ileocecal valve. Then all mesenteric,
neural and lymphatic connections to the jejunoileum, excluding the superior mesenteric
vessels, were transected. The superior mesenteric artery and vein, and their single colic
branches arising distal to the main trunks, were skeletonized down to the level of the adventitia
for a length of 2 cm. Thus, the stripped superior mesenteric vessels (and their single colic
branches) remained as the only connections, maintaining undisturbed blood flow to the
jejunoileum without ischemia. Approximately 30 cm of the proximal jejunum had to be
resected in order to ascertain uncompromised blood flow to the proximal watershed area. Our
model of in situ jejunoileal autotransplantation (n = 11, of which 5 were postoperatively treated
with GH) was continued with clamping the skeletonized mesenteric vessels to produce total
jejunoileal ischemia (IV, unpublished). Thereafter, the superior mesenteric artery was
cannulated distal to the clamping site and the isolated jejunoileum was flushed macroscopically
bloodless in about 15 minutes with heparinized (5000 IU/L) cold (+4 ºC) Ringer’s solution
(500-ml) as described by Lillehei et al. (1959). A small incision on the superior mesenteric vein
was made to allow outflow of the effluent. After the flushing, another vascular clamp was
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introduced more distally in the mesentery, while the others were removed, allowing
undisturbed blood flow through the colic artery and vein arising distal to the main trunks again.
The colic branches were occluded during the flushing in order to prevent the escape of the
flushing solution into the colic circulation, while preventing venous inflow into the jejunoileal
circulation from colic vasculature. However, the colon appeared macroscopically normal with
unchanged color, suggesting that no significant ischemia had occurred. After closure of the
small lesions in the superior artery and vein, the distal vascular occlusion was removed,
allowing free reperfusion of the jejunoileum. A mean ischemia time of 45 minutes was used.
Intestinal continuity was restored with end-to-end anastomoses and peritoneal and mesenteric
defects were carefully closed.
First stage (I–III)
Preoperative Transection    Resection Resection + Autotx
⇒ ⇒ ⇒
Second stage (IV, unpublished)
Laparotomy Transection       Denervation Autotransplantation
  (without ischemia)    (with ischemia)
⇒ ⇒    or
FIGURE 2. Schematic presentation of the operative design of first and second stage studies.
Autotx = Autotransplantation. The shaded area represents denervated or autotransplanted small
bowel.
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GROWTH HORMONE TREATMENT
Single 0.1 U/kg subcutaneous dose of human recombinant GH (Zomacton; Ferring, Espoo,
Finland) was given daily to the animals in the GH + in situ jejunoileal autotransplantation
group. Treatment was given similarly throughout the eight-week follow-up period, and the dose
was checked weekly according to the body weight.
MORPHOLOGY
Ten-centimeter sections of the proximal jejunum, mid- and distal ileum and proximal colon
were collected for the gross morphometric analyses of the first stage studies. In study I all these
sampling sites were analyzed. Since the alterations in the mid- and distal ileum were similar but
more pronounced in the former, only jejunum, mid-ileum and colon were investigated in study
II. Changes of the colon were generally negligible and thus are no further discussed in this
thesis. Only ileal segments were included in study III. Similar sections of proximal jejunum and
distal ileum were collected and studied in the second stage. The collected small bowel samples
were first opened from the anti-mesenteric border, then the bowel circumference and serosal
area was measured and the samples were weighed. Then by gently scraping with a specimen
slide the mucosa was removed, weighed, snap-frozen in liquid nitrogen and stored at –20 ºC for
later use in the mucosal protein and brush border enzyme activity analyses. Additional 3-cm
sections from corresponding sites were fixed in formalin and prepared according to the routine
histochemical methods with Periodic acid Schiff (PAS) staining for the histomorphometric
measurements. Multiple histologic variables (mucosal and muscular thickness, villus height
and width, density of villi and crypts, number of goblet cells in villi and goblet cell density in
crypts, villous and cryptal enterocyte and intraepithelial leukocyte density) were measured
under light microscope from four randomly chosen sites per each full thickness small bowel
biopsy. The author made all of the histomorphometric analyses in a blind review. The villus
surface area was calculated using the formula for the surface area of the convex surface of the
cylinder: surface area = 2πrh (r = villus width/2, h = villus height). Some histomorphometric
variables were not measured in every study, and only the changes in the main mucosal
histomorphometric variables are discussed in this thesis.
ELECTRON MICROSCOPY
Ultrastructural analysis of enterocytes was performed only in the second stage studies (IV,
unpublished). Mucosal biopsies were obtained from proximal jejunum and distal ileum from
two randomly chosen pigs per each study group for ultrastructural analyses. Biopsies were
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fixed in 2.5% solution of glutaraldehyde in 0.1 M phophate buffer for 2 hours. Fixed biopsies
were then washed twice with phosphate buffer and then stored in phophate buffer at +4 ºC. The
samples were post-fixed in osmium tetroxide, dehydrated in graded ethanol solutions and
propylene oxide, and embedded in epoxy resin LX 112, using conventional methods. Toluidine
blue stained semithin sections were examined under light microscope and the areas of villi and
crypts were chosen for the electron microscopic analyses. The ultrathin sections for electron
microscopic studies were stained with uranyl acetate and lead citrate. The overall mucosal
ultrastructure was analyzed, and cryptal and mid-villous areas were photographed with
transmission electron microscopy (magnification 5000X–7500X). Microvillus height and
density (the number of microvilli per 5 µm) of mid-villous enterocytes were measured from
four randomly selected sites per each biopsy. In addition, details of villous enterocyte
ultrastructure were semi-quantitatively analyzed in a blind review by scoring the structure of
the brush border, junctional complex, intercellular spaces, mitochondria, nucleus, and Golgi
apparatus from 0 to 3 (0 = normal structure, 1 = slightly altered, 2 = moderately altered, and 3 =
severely altered).
IMMUNOHISTOCHEMICAL STUDIES
Before the immunohistochemical studies, the function of all used mono- and polyclonal
primary antibodies (Table 5) in porcine tissues were tested by using appropriate positive
controls. Proliferative crypt cells were detected with MIB-1 antibody against Ki-67 antigen (I–
IV). The MIB-1 immunostainings were performed either by using the routine streptavidin-
biotin method with Zymed Histostain-SP kit (suitable for mouse, rabbit, guinea pig and rat
primary antibodies; Zymed, San Francisco, USA; I–III) or with a Techmate 500 immunostainer
using a Dako ChemMateTM visualization kit with 3-amino-9-ethylcarbazole (AEC) as
chromogen (Dako, Glostrup, Denmark; IV). Before routine immunohistochemistry the paraffin-
embedded tissue samples, mounted into 3-amino-propyletoxysilan coated slides (Sigma, St.
Louis, USA) or into SuperFrost® Plus slides (Menzel-Gläser, Braunschweig, Germany) were
first deparaffinated and then incubated in a microwave oven (3x5 min, 750W) in 10 mM citrate
buffer. After the microwave oven treatment, the sections were incubated with normal blocking
serum at room temperature for 30 minutes, and then with MIB-1 primary antibody overnight.
On the second day, the sections were first washed in phosphate buffered saline (PBS) for 3x5
minutes, incubated with a secondary antibody for 30 minutes, washed again in PBS and then
incubated in streptavidin-biotinylated peroxidase for 30 minutes. After re-washing in PBS, the
sections were incubated in AEC with N´N´-dimethylformamide and hydrogen peroxide for 20
minutes. The slides were counterstained with hematoxylin and mounted in Aquamount (BDH
Chemicals Ltd., Poole, UK).
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Enteroendocrine cells were detected by using chromogranin A antibody. Antibodies against
somatostatin, neurotensin and glicentin were used for the differentiation of the enteroendocrine
cell subtypes (III). For chromogranin A and glicentin primary antibodies the slides were first
incubated in a microwave oven with citrate buffer as described above. Trypsin pretreatment (25
minutes at +37 °C) was performed before incubation with the somatostatin antibody. The
neurotensin antibody incubation was performed without pretreatment. The chromogranin A
immunostainings were performed with a Techmate 500 immunostainer using a Dako
ChemMateTM visualization kit with AEC as chromogen (Dako). Other immunostainings were
performed with the routine streptavidin-biotin method using Zymed Histostain-SP kit (Zymed)
as described in detail above. The accomplishment of denervation was tested by staining
catecholinergic nerve fibers from ileal samples using the antibody against tyrosine hydroxylase
(IV) with microwave oven pretreatment and streptavidin-biotin method of Zymed Histostain-
SP kit (Zymed).
TABLE 5. Primary antibodies used for immunohistochemical stainings.
Antibody Source Cat. No.
Mouse anti-human ki-67 antigen (MIB-1) Immunotech, Marseilles, France 0505
Rabbit anti-human chromogranin A Dako, Glostrup, Denmark A 0430
Rabbit anti-human somatostatin Dako A 0566
Rabbit anti-bovine neurotensin Monosan, Uden, The Netherlands PS090
Rabbit anti-porcine glicentin Monosan PS086
Mouse anti-human tyrosine hydroxylase Novocastra, Newcastle upon Tyne, UK NLC-TH
MIB-1 positive proliferative crypt cells were counted from four randomly chosen crypts after
excluding areas of Payer’s patches. Crypt depth and total number of crypt cells were also
measured from the MIB-1 stained slides, and the proliferation index (the percentage of
proliferating crypt cells of the total number of crypt cells) was calculated. The enteroendocrine
cells were counted from twelve randomly chosen crypts and the mean number of
enteroendocrine cells per crypt and the enteroendocrine cell index (the percentage mean
number of enteroendocrine cells per crypt of the number of all crypt cells) were calculated. The
enteroendocrine cell subtypes were differentiated by counting the cells expressing somatostatin,
neurotensin and glicentin from twelve randomly chosen light microscope visual fields (area of
1.3 mm2 at magnification 200X) including both villous and cryptal areas. Due to technical
difficulties, only three animals in each group were included into the enterocyte subtype
distribution studies, and thus the changes in these were not statistically compared.
DISACCHARIDASE ACTIVITIES
Brush border disaccharidase activities were determined according to the method of Dahlqvist
(1968). The mucosal protein content was measured using the method of Lowry et al. (1951),
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and the specific activities of maltase, sucrase and lactase were defined as the enzyme activity of
the mucosal protein (expressed as U/g of mucosal protein). The total disaccharidase activities
were defined as the enzyme activity in a given small bowel area expressed either as U/dm2 of
serosal area (I, II) or as U/cm of small bowel length (IV). Therefore, the total activity describes
the capacity of the disaccharidase activity of the small bowel segment.
STATISTICS
In general, the analysis of variance with Fisher’s protected least significant difference test for
the multiple pairwise comparisons and the unpaired two-tailed Student’s t-test were used for
the statistical comparisons between and within the groups (I, II and IV). In study III, non-
parametric comparisons between and within the study groups were made with the Kruskal-
Wallis test and Mann-Whitney U-test. In study IV, the differences in the disaccharidase
activities were compared with the Kruskal-Wallis test between the groups and with the
Wilcoxon signed rank test within a group. Unless otherwise mentioned, all values are
expressed as mean ± standard error of the mean and p-values < 0.05 were considered
statistically significant.
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RESULTS 
 
 
POSTOPERATIVE STATUS AND BODY WEIGHT GAIN 
 
 
All animals included in these studies appeared healthy and had good appetite during the follow-
up. However, diarrhea or softened stools were seen in the animals of the resection (I–III) and 
resection + autotx (II, III) groups for 3.0 ± 0.4 and 4.7 ± 0.4 weeks after the operations, 
respectively. Similarly, two pigs in the jejunoileal denervation group and two in the in situ 
jejunoileal autotransplantation group (IV) had postoperative diarrhea for one to two weeks 
postoperatively. 
 
At the onset of the first stage studies (I–III), the preoperative weights of the experimental 
animals ranged from 16 to 22 kg with no significant differences among the transection, 
resection and resection + autotx groups. Food intake increased significantly in the resection and 
resection + autotx groups (32 ± 2 g/kg/day and 36 ± 4 g/kg/day, respectively) compared with 
the transection group (25 ± 1 g/kg/day). However, the transected controls gained significantly 
more weight than the animals in the resection group, and especially more than in the resection 
+ autotx group (Figure 3). The preoperative weights of the animals included in the second stage 
studies ranged from 17 to 24 kg (IV). The mean preoperative weights of the animals in the 
laparotomy and transection groups were slightly but significantly smaller compared with the 
other groups. However, the extrinsic denervation and autotransplantation of the jejunoileum 
significantly decreased the percentage body weight gain of the animals having standardized 
food intake (Figure 3). Growth hormone therapy significantly enhanced body weight gain after 
in situ jejunoileal autotransplantation. 
 
 
FIGURE 3. Percentage weight gains during fourteen and eight week follow-up of first and second stage 
studies, respectively. Mean ± SEM. * p < 0.05 vs. Laparotomy and Transection, # p < 0.05 vs. 
Resection, + p < 0.05 vs. Denervation and Autotx. Autotx = Autotransplantation, GH = growth 
hormone 
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SMALL BOWEL MORPHOLOGY
Small Bowel Adaptation after Resection and Ileal Autotransplantation
The length of the remaining ileum in the resection group increased significantly more (by 69%)
than the length of the corresponding ileal segment in the transection group (by 14%) during the
14-week follow-up (I). In contrast, the length of the autotransplanted ileal remnant remained
virtually unchanged (II). Resection increased the diameter, wet weight, and mucosal wet weight
of the remaining small bowel compared with the transection controls. These changes were most
prominent in the mid-ileum (Table 6; I). Mucosal protein content, expressed as mg/cm2 of
serosal area, also increased after resection in mid-ileum (I), but when expressed as mg/g of
mucosal mass this difference was not observed (unpublished result). The diameter and wet
weight of the small bowel remnant increased also in the autotransplanted pigs during the 14
week follow-up, but remained markedly below the resection group values. The mucosal wet
weight was uniformly decreased in the remaining small bowel after autotransplantation
compared with resection (Table 6; II). The mucosal protein content expressed as mg/g of
mucosa was significantly lower in the autotransplanted animals compared with resected
controls at weeks 4 and 8, but not at week 14 (II).
TABLE 6. The main jejunal and mid-ileal morphologic and proliferative variables at week 14 after small
bowel transection (I), resection (I, II), and ileal remnant autotransplantation (II).
JEJUNUM Transection Resection Resection + Autotx
Bowel diameter (cm) 1.45±0.05 2.24±0.09 ∗ 1.71±0.06 #
Bowel wet weight (g/cm) 1.51±0.07 2.76±0.21 ∗ 1.45±0.12 #
Mucosal wet weight (mg/cm2 of serosa) 427±53 608±103 379±40 #
Villus height (µm) 599 ± 47 764 ± 47 ∗ 486±34 #
Villus surface area (mm2) 0.26 ± 0.03 0.34 ± 0.01 0.19±0.01 #
Crypt depth (µm) 436 ± 26 519 ± 26 385±18 #
Proliferative cells (No./crypt) 28±2 51±7 ∗ 30±2 #
Proliferation index (%) 23±2 27±2 20±2 #
MID-ILEUM
Bowel diameter (cm) 1.34±0.04 2.25±0.04 ∗ 1.76±0.07 #
Bowel wet weight (g/cm) 1.15±0.06 2.72±0.14 ∗ 1.06±0.08 #
Mucosal wet weight (mg/cm2 of serosa) 346±37 551±34 ∗ 225±15 #
Villus height (µm) 621 ± 25 919 ± 68 ∗ 485±31 #
Villus surface area (mm2) 0.29 ± 0.01 0.37 ± 0.03 ∗ 0.17±0.02 #
Crypt depth (µm) 312 ± 15 483 ± 19 ∗ 314±14 #
Proliferative cells (No./crypt)  27 ±1 62±3 ∗ 36±3 #
Proliferation index (%) 25±1 32±2 ∗ 28±4
The values are expressed as mean ± SEM. ∗ p < 0.05 vs. Transection, # p < 0.05 vs. Resection. Statistical
analyses between Resection vs. Transection, and Resection + Autotx vs. Resection were performed
separately in studies I and II using Student’s t-test. Autotx = autotransplantation.
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The proximal small bowel resection increased the villus height and surface area, and the crypt
depth in the remaining small bowel (Table 6; I). This resection-induced increase in the villus
height and surface area in the remaining small bowel was significantly suppressed by the
autotransplantation, demonstrated at 8-week and 14-week follow-up periods in the jejunum
and ileum, respectively. Furthermore, at week 14, the crypt depth was significantly lower in
the remaining small bowel of the autotransplanted pigs compared with the resected controls
(Table 6; II). The density of epithelial cells in villi was significantly decreased in the remaining
ileum after resection. In contrast, the crypt cell density increased in the proximal jejunum and
mid-ileum, but not in the distal ileum after resection (I). After ileal autotransplantation, the
villous epithelial cell density in the jejunum remained unchanged, but increased in the ileum
significantly above the resection group values, whereas the changes in the crypt cell density
were less constant (II).
Morphology of the In Situ Jejunoileal Autotransplant – the Effect of GH
Immunohistochemical staining with tyrosine hydroxylase antibody showed intense positive
staining of the catecholaminergic neurons in the myenteric and submucosal nerve plexuses
eight weeks after sham laparotomy and jejunal transection. In contrast, no staining was
observed in the denervation and autotransplantation groups indicating complete extrinsic
denervation with no signs of reinnervation (IV). Growth hormone had no effect on this
phenomenon (unpublished result).
Jejunoileal circumference and segmental small bowel weight and mucosal wet weight were
virtually similar in the laparatomy, transection, denervation, and autotransplantation groups
(Table 7; IV). Mucosal protein content was similar between different groups in the jejunum,
while inconsistent changes occurred in the ileum (IV). Histomorphometric changes after
jejunoileal denervation with or without IRI were altogether minor. However, some differences
were observed in a few variables. Villus height increased in the ileum after extrinsic
denervation and autotransplantation. Ileal crypt depth decreased after transection and
autotransplantation when compared with the laparotomy group, but remained unaltered in the
denervation group (Table 7; IV). Villous enterocyte density decreased in the ileum, but the
crypt cell density remained unchanged. In the jejunum, the crypt cell density increased
significantly after denervation and autotransplantation. When denervation and
autotransplantation groups were compared with each other, the only significant difference was
the higher mucosal protein content in the ileum of the autotransplantation group (IV).
Confusingly, this difference vanished after GH therapy (data not shown). Altogether, the
mucosal characteristics were virtually equal after GH treatment compared with non-treated in
situ jejunoileal autotransplantation controls (Table 7; unpublished data).
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The overall enterocyte ultrastructure appeared normal after laparotomy, transection,
denervation and autotransplantation (IV). Enterocytes of the villus tip had higher and better-
organized microvilli than those seen in the crypts or in the base of the villi. Semi-quantitative
analysis showed few slightly dilated intercellular spaces and some swollen Golgi apparatuses
and mitochondria (scored as grade 1 alterations) distributed uniformly in the jejunal and ileal
samples of all study groups, but all other variables were normal (scored as grade 0). The
microvillus height and density of the middle villous enterocytes were similar between the
different groups (Table 7; IV). Growth hormone after jejunoileal autotransplantation had no
effect on the enterocyte ultrastructure (Table 7; unpublished data).
TABLE 7. Main structural and proliferative variables of the second stage studies (IV, unpublished data) at eight
weeks postoperatively.
JEJUNUM Laparotomy Transection Denervation Autotx    GH + Autotx
Bowel circumference (cm) 3.8 ± 0.2 3.6 ± 0.2 4.0 ± 0.1 4.4 ± 0.3 4.5 ± 0.3
Bowel wet weight (g/cm) 1.32 ± 0.08 1.26 ± 0.11 1.40 ± 0.10 1.46 ± 0.15 1.53 ± 0.15
Mucosal wet weight (mg/cm) 805 ± 66 786 ± 62 811 ± 61 829 ± 75 924 ± 100
Villus height (µm) 700 ± 62 694 ± 37 771 ± 59 681 ± 62 677 ± 33
Villus surface area (mm2) 0.31 ± 0.02 0.32 ± 0.02 0.41 ± 0.05 0.32 ± 0.02 0.31 ± 0.01
Crypt depth (µm) 433 ± 15 426 ± 25 388 ± 22 378 ± 9 355 ± 18
Microvillus height (µm) 1.9 ± 0.1 1.6 ± 0.2 1.6 ± 0.2 2.2 ± 0.4 1.7 ± 0.1
Microvilli (No./5 µm) 40.3 ± 1.5 41.9 ± 1.6 41.4 ± 0.1 39.6 ± 2.1 39.5 ± 2.3
Proliferative cells (No./crypt) 71 ± 3 70 ± 6 68 ± 5 83 ± 4 79 ± 2
Proliferation index (%) 57 ± 2 53 ± 2 54 ± 3 62 ± 2 61 ± 1
ILEUM
Bowel circumference (cm) 3.5 ± 0.1 3.9 ± 0.1 3.8 ± 0.1 3.8 ± 0.1 3.8 ± 0.2
Bowel wet weight (g/cm) 1.31 ± 0.10 1.12 ± 0.10 1.37 ± 0.07 1.32 ± 0.08 1.19 ± 0.04
Mucosal wet weight (mg/cm) 556 ± 41 563 ± 35 529 ± 24 538 ± 32 517 ± 25
Villus height (µm) 492 ± 14 546 ± 24 648 ± 20 *# 622 ± 38 * 645 ± 31
Villus surface area (mm2) 0.23 ± 0.02 0.25 ± 0.02 0.31 ± 0.02 *# 0.28 ± 0.02 0.26 ± 0.01
Crypt depth (µm) 378 ± 13 308 ± 14 * 363 ± 10 # 326 ± 15 * 312 ± 7
Microvillus height (µm) 2.2 ± 0.04 2.2 ± 0.1 1.9 ± 0.3 2.1 ± 0.6 1.7 ± 0.1
Microvilli (No./5 µm) 39.9 ± 1.1 39.9 ± 1.4 40.3 ± 1.0 39.1 ± 1.9 40.5 ± 0.3
Proliferative cells (No./crypt) 81 ± 8 64 ± 6 68 ± 5 77 ± 6 70 ± 8
Proliferation index (%) 71 ± 2 61 ± 4 58 ± 5 68 ± 4 64 ± 8
The values are expressed as mean ± SEM. * p < 0.05 vs. Laparotomy, # p < 0.05 vs. Transection. The analysis of
variance with Fisher’s protected least significant difference test was performed between the Laparotomy,
Transection, Denervation and Autotx groups (IV). GH + Autotx group was separately compared with Autotx using
unpaired Student’s t-test. The values of the number of microvilli and microvillus height were not statistically
compared. Autotx = in situ jejunoileal autotransplantation, GH = growth hormone.
CRYPT CELL PROLIFERATION
Proliferation after Small Bowel Resection and Ileal Autotransplantation
The number of proliferating crypt cells and the total number of crypt cells increased in the
small bowel after resection. Thus, the proliferation index was only modestly higher in the
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resection group than in the transected controls. However, this difference was significant in the
mid-ileum (Table 6; I). Compared with the resection group, the number of proliferating crypt
cells of the jejunum and mid-ileum decreased between 8 and 14 postoperative weeks after
autotransplantation of the ileal remnant. However, since the total number of crypt cells
underwent a proportionally similar decrease in the mid-ileum, the proliferation index was
significantly decreased at the end of the 14-week follow-up only in the jejunum (Table 6; II).
Proliferation after Jejunoileal Autotransplantation – the Effect of GH
Both in the jejunum and the distal ileum, the total number of crypt cells, the number of
proliferative crypt cells and the proliferation index remained unchanged after transection,
denervation and in situ jejunoileal autotransplantation compared with the sham laparotomy
(Table 7; IV). Growth hormone had no effect on the crypt cell proliferation (Table 7;
unpublished data). The proliferation indexes were higher in the second stage studies (IV,
unpublished data), in which the MIB-1 immunostainings were performed using Techmate 500
immunostainer than in the first stage studies (I–III).
BRUSH BORDER DISACCHARIDASES
Disaccharidase Activities after Small Bowel Resection
The most prominent resection-induced changes in the specific activities of maltase and sucrase
were observed in the mid-ileum, where the activities of these two disaccharidases were
decreased after resection compared with the transection (I). In contrast to the specific activities,
the total activities of maltase and sucrase were nearly similar in the resection group than in the
transected control group. Resection had no significant effect on the specific or total activity of
lactase when compared with transection.
Effect of Ileal Remnant Autotransplantation on Disaccharidase Activities
The specific ileal, but not jejunal, maltase and sucrase activities tended to be higher in the
autotransplanted versus intact ileum after small bowel resection (II). The specific lactase
activity in the ileum remained virtually unchanged after autotransplantation. However, the total
activities of all the three disaccharidases studied tended to decrease in the jejunum and
especially in the ileum after remnant ileal autotransplantation when compared with the
resection group. However, only the differences in the total ileal lactase activity uniformly
reached statistical significance.
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Disaccharidases after Jejunoileal Autotransplantation – the Effect of GH
The variation within the specific and total disaccharidase activities was large and no
statistically significant differences between the laparotomy, transection, denervation and in situ
jejunoileal autotransplantation groups were observed (data not shown). However, the proximal
to distal gradient of specific sucrase activity in the sham laparotomy and transection groups was
abolished after denervation and autotransplantation mainly due to decreased ileal activities
(IV). GH-therapy after jejunoileal autotransplantation had no significant effect on the mucosal
disaccharidase activities (unpublished data).
ILEAL ENTEROENDOCRINE CELLS
Enteroendocrine Cells after Small Bowel Resection
No statistically significant differences were observed in the crypt enteroendocrine cell number
and the enteroendocrine cell index between the transection and resection groups (Figure 4; III).
In the resection group, there were significantly more enteroendocrine cells per crypt in the
proximal ileal remnant compared with the distal ileum, indicating proximal to distal gradient in
the enteroendocrine cell expression. In the transection group, most of the mucosal
enteroendocrine cells were glicentin-expressing cells, followed by the somatostatin-expressing
cells as the second largest group, and the neurotensin-expressing cells as the smallest group.
The distribution of the enteroendocrine cell subtypes in the resection group was virtually
similar to the transection group (III).
FIGURE 4. The mean number of ileal enteroendocrine cells per crypt (A), and the enteroendocrine cell index (B)
14 weeks after small bowel transection, resection and remnant ileum autotransplantation. The values are expressed
as mean ± SEM. ∗ p < 0.05 vs. Resection, # p < 0.05 vs. Transection. Autotx = Autotransplantation.
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Effect of Autotransplantation on Ileal Enteroendocrine Cells
There were less ileal crypt enteroendocrine cells in the resection + autotx group compared with
the resection group, but the difference was significant only in the proximal ileal remnant
(Figure 4; III). When compared with the transection and resection groups, the proportion of
enteroendocrine cells to the total number of crypt cells markedly decreased in the resection +
autotx group. However, the difference was significant only in the distal end of the remaining
ileum. The proximal to distal gradient of the enteroendocrine cell count that was seen after
resection was abolished when the ileal remnant was subjected to autotransplantation. In
addition, the number of somatostatin-expressing cells in both ends of the ileal remnant and the
number of glicentin-expressing cells in the proximal end of the ileal remnant decreased in the
resection + autotx group when compared to the other groups (III).
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DISCUSSION
POSTRESECTIONAL SMALL BOWEL ADAPTATION
Our first goal was to create a suitable large animal model of SBS, which we could further use
as a control for the following studies of partial small bowel transplantation. Thus, a massive
75% proximal small bowel resection was performed to growing piglets and the weight gain and
the adaptive changes of the remaining small bowel were monitored. Despite compensatory
hyperphagia, the animals in the resection group gained significantly less weight compared with
the normally eating transection group pigs (I). This finding suggests that in vivo nutrient
absorption was impaired after small bowel resection, indicating that our model of 75%
proximal small bowel resection causes SBS in growing pigs.
The proximal small bowel resection in our porcine model caused the well-known adaptive
morphologic changes of the remnant small bowel (Williamson 1978, Dowling 1982). The
length of the remaining ileum in the resection group increased significantly more than the
length of the corresponding ileal segment in the transection group. In addition, the resection
significantly increased the diameter, segmental wet weight, and mucosal wet weight of the
remaining small bowel. Further, the proximal small bowel resection increased the villus height
and surface area, and crypt depth in the remaining small bowel, indicating that both
macroscopic and histologic enlargements are involved in the adaptive response to small bowel
resection in our large animal model. These changes were accompanied with high crypt cell
proliferation rate, similarly as observed in rodents (Hanson et al. 1977a, Helmrath et al. 1996)
(I). Our results of histologically observable adaptive changes of the postresectional porcine
small bowel remnant corroborate the findings of other porcine models (Heemskerk et al. 1999).
In contrast, Sigalet et al. (1990) found that the small bowel dilatation and lengthening, rather
than the increase in villus height or crypt depth, were the most crucial adaptive alterations in
pigs after 75% mid-small bowel resection. In addition, massive distal small bowel resection in
dogs has produced only gross morphologic alterations into the small bowel remnant, but no
increase in the villus height (Quigley and Thompson 1993).
The differences between the study protocols may describe some of the discrepancies between
our results and the findings of the others. Most importantly, we used proximal small bowel
resection and studied the adaptive changes of the proximal jejunum and the ileal remnant. The
morphologic adaptation is greater in the ileum after jejunal resection than vice versa, indicating
that the ileum has more adaptive capacity compared with the jejunum (Dowling 1982,
Thompson et al. 1999a). However, the terminal ileum may remain structurally unchanged after
resection (Nguyen et al. 1996, Thompson et al. 1996). Our finding that the morphologic
changes were more pronounced in the mid-ileum compared with the other studied segments of
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the small bowel remnant is comparable with previous reports. Therefore, it is not surprising
that a massive mid- or distal small bowel resection may not be associated with the growth of
mucosal structures of the small bowel remnant (Sigalet et al. 1990, Quigley and Thompson
1993).
In the clinical situation, the distal small bowel resection is more often performed than the
proximal resection. Thus, the fact that the distal small bowel resection may not be followed by
similar histomorphometric adaptive changes as the proximal resection may partly explain the
lack of the adaptive mucosal growth observed in patients with SBS (Porus 1965, O’Keefe et al.
1994). The reason for the poor adaptation of the proximal gut is currently unsolved. In theory,
jejunal structures may not have similar adaptive potential as ileal structures. However, more
likely explanation is the impaired humoral adaptive response following distal small bowel
resection. Intestinal enteroendocrine cells, which secrete intestinotrophic peptide hormones, are
not evenly distributed along the proximal to distal axis of the small bowel. Proglugacon-
derived peptides, especially GLP-2, expressing L-cells are mainly located in the ileum (Green
et al. 1989). Thus, a massive ileal resection diminishes GLP-2 production, which may impair
the adaptive response (Jeppesen et al. 1999). Interestingly, a tendency for adaptive mucosal
growth was recently observed after GLP-2 treatment in patients with SBS, proposing that such
hormonal treatment may in the future be a part of the treatment strategy of SBS (Jeppesen et al.
2001).
ADAPTATION OF THE SEGMENTAL SMALL BOWEL GRAFT
The most obvious alteration after autotransplantation of the ileal remnant in our studies was the
significantly poorer weight gain compared with the resection (II). Since the food intake was
similar in these groups, it seems that the absorptive function of the small bowel was more
severely impaired in the segmental ileal autotransplantation group compared with the resection
group. However, despite the presumably impaired absorptive function of the graft, the pigs
survived, suggesting that a segmental small bowel transplant could be used as an alternative to
a small bowel graft of entire length.
The structural adaptation of the segmental small bowel graft would eventually improve the
absorptive function of the graft. Studies in rats have shown morphologic adaptation in the
transplanted small bowel segment similar to that seen after small bowel resection (Kimura et
al. 1988, Kirsch et al. 1991, Rahman et al. 1996, Ferguson and Thompson 2000). Accordingly,
we intended to characterize the adaptive changes of the segmental small bowel graft in the
porcine model. Ileal segment autotransplantation was used since both the intact and
transplanted ileum have greater morphologic adaptive potential than the jejunum (Dowling
1982, Rahman et al. 1996, Thompson et al. 1999a). In addition, it has been suggested that the
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ileal graft may have functional benefits compared with the jejunal graft (Kiyozaki et al. 1996,
Thompson et al. 1999b).
Opposite to previous reports in rats (Kimura et al. 1988, Kirsch et al. 1991, Rahman et al.
1996, Ferguson and Thompson 2000) we showed for the first time in a large animal model that
small bowel adaptation is impaired after autotransplantation, at least during the first 14 weeks
postoperatively. In contrast to the increased remnant small bowel length after proximal small
bowel resection, the length of the autotransplanted ileal remnant remained virtually unchanged
in our porcine model. In addition, the diameter, wet weight, and mucosal wet weight of the
small bowel were markedly lower than the resection group values at the end of the study.
Histomorphometric analysis confirmed this inhibition of the structural adaptation of the
segmental small bowel graft, since the resection-induced increase in the villus height, villus
surface area, and crypt depth was suppressed by the autotransplantation. In addition, the
hyperproliferative crypt cell response, which was observed after the resection, was inhibited by
the autotransplantation of the ileal remnant (II). This finding suggests that the increased crypt
cell proliferation is essential in the normal postresectional small bowel adaptation in pigs.
The maladaptation after segmental ileal autotransplantation was seen in both the intact jejunal
remnant and the ileal graft. This finding implies that the inhibited small bowel adaptation after
ileal remnant autotransplantation may be due to some small bowel denervation or IRI-related
systemic factor. However, the effects of local factors such as bacterial overgrowth were not
ruled out in our study. Previous studies by our group have demonstrated impairments in the
nutrient absorption after segmental small bowel autotransplantation in pigs (Pakarinen 1996a
and 1996b). Thus, the malnutrition in pigs with segmental ileal small bowel autograft may have
had a role in the poor morphologic small bowel adaptation. In fact, the adaptive response after
small bowel resection is inhibited in malnourished rats, which supports our conclusion (Cronk
et al. 2000). However, the poor weight gain may also be a secondary phenomenon due to the
impaired adaptive growth of the remaining small bowel. As the decrease in the enteroendocrine
cell expression and the changes in the enteroendocrine cell subtype distribution after ileal
remnant autotransplantation suggest, some alterations in the humoral adaptation regulation may
also be involved in the poor postresectional adaptation after partial ileum autotransplantation.
STRUCTURE AND FUNCTION OF THE SMALL BOWEL AFTER NEURAL ISOLATION
The disconnection of the lymphatic pathways and the extrinsic denervation of the jejunoileum
with or without ischemia and reperfusion similarly impaired the weight gain of the growing
pigs having standardized food intake (IV), which implies that IRI has no long-term effects on
the overall growth of the pigs. Lymphatic pathways of the experimental animals have been
shown to regenerate in few weeks after small bowel transplantation (Kocandrle et al. 1966,
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Schier et al. 1991). Thus, it seems unlikely that the disruption of the lymphatics would cause
long-term alterations in the absorptive function of the small bowel graft. However, recent
evidence in rats suggests that lymphatic disruption may cause long-term impairment of weight
gain after small bowel transplantation (Kellersman et al 2000). In contrast to the regeneration
of the lymphatic pathways, the extrinsic reinnervation may take months or years to be complete
(Kiyochi et al. 1995, Sugitani et al. 1998). No sign of reinnervation was observed in our study
eight weeks after denervation. Thus, these findings suggest that the extrinsic denervation is the
most likely transplantation procedure-related reason for the diminished weight gain after in situ
jejunoileal autotransplantation in pigs, although effects of lymphatic disconnection could also
be involved. In addition, our findings with jejunoileal denervation and autotransplantation
models propose that denervation, and probably also lymphatic disconnection, rather than IRI
may have been the underlying reason for impaired weight gain also after segmental small bowel
autotransplantation (II).
Experimental animals suffer from diarrhea and weight loss during the first postoperative weeks
after small bowel denervation and transplantation (Thompson et al. 1992, Sarr et al. 1996).
This period of transient diarrhea is probably associated with the reversible denervation-induced
impairment in water and electrolyte absorption, but IRI-related mucosal injury may also be
involved (Herkes et al. 1994, Oishi and Sarr 1995, Takeyoshi et al. 2001). Four animals in our
study, two in the denervation and two in the in situ autotransplantation group, had diarrhea
during the first one or two postoperative weeks. However, in addition to those animals, poor
weight gain was also observed in other animals included into the groups, suggesting that in all
pigs the nutrient absorption ability of the denervated jejunoileum was abnormal throughout the
follow-up leading to the impaired weight gain.
The overall small bowel structure, enterocyte ultrastructure, and gross morphometric variables
were similar in pigs after small bowel denervation and jejunoileal autotransplantation
compared with the sham laparatomy and transection controls (IV). These findings are
consistent with most of the previous reports that have demonstrated only transient IRI-related
changes in the small bowel structure of the non-rejecting small bowel grafts, or normal small
bowel morphology after complete neural isolation of the small bowel (Teitelbaum et al. 1989,
Thompson et al. 1992, Ishii et al. 1993, Sarr et al. 1996). Since the overall structure and
histomorphometric characteristics of the denervated and autotransplanted small bowel were not
altered, it seems possible that the impaired weight gain after these procedures was a result of
changes in the nutrient uptake ability of the individual enterocytes. In fact, this explanation is
supported by findings that the carrier-mediated nutrient uptake ability is impaired after
jejunoileal denervation in dogs (Oishi et al. 1996, Foley et al. 1998).
Unexpectedly, the villus height increased in the ileum after extrinsic jejunoileal denervation
and in situ autotransplantation (IV). Mucosal growth has also been reported in rats with small
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bowel isografts of entire length (Ferguson and Thompson 2000). The reason for the adaptive
growth of the small bowel graft mucosal structures is unknown, but it may be a compensatory
phenomenon due to impaired nutrient absorption. However, the underlying mechanisms
leading to the adaptive mucosal changes in the denervated ileum are unknown. A short segment
(approximately 30-cm) of the proximal jejunum had to be resected in our study during the
denervation and autotransplantation of the jejunoileum. However, it is unlikely that this short
small bowel resection was able to cause adaptive mucosal growth similar to that usually seen
after massive small bowel resection. Neural isolation of the small bowel is shown to increase
the tissue and plasma levels of several gut hormones (Evers et al. 1990, Nelson et al. 1993,
Adrian et al. 1994). Thus, expression of some intestinotrophic gut hormone may have been
increased after jejunoileal denervation in pigs, which may have caused the growth of the ileal
villi. However, increase in the crypt cell proliferation was not seen after jejunoileal
denervation, suggesting that other mucosal growth regulating systems, such as alterations in the
enterocyte apoptosis, may have been involved. Unfortunately the apoptotic rate was not studied
in our investigation and thus this explanation could not be proven.
ENTEROENDOCRINE SYSTEM AND THE SMALL BOWEL ADAPTATION
No statistically significant differences were observed in the ileal enteroendocrine cell number
or in the enteroendocrine cell index between the transection and resection groups in our study
(III). In addition, the resection did not alter the distribution of the enteroendocrine cell
subtypes. These findings were expected, since the enhanced enteroendocrine cell function,
rather than the increased enteroendocrine cell number, is known to be responsible for the
extended enterotrophic hormone production after small bowel resection (Buchan et al. 1985,
Fuller et al. 1993).
Increased numbers of different gut enteroendocrine cells have been observed after small bowel
transplantation in experimental animals (Deltz et al. 1987, Takeyoshi et al. 2001), and no
change in the expression of different enteroendocrine cells was observed by Sugitani and
colleagues (1994) in a removed human small bowel transplant. In contrast, we found less ileal
crypt enteroendocrine cells and a reduced enteroendocrine cell index in the segmental ileal
autotransplantation group compared with the resection group (III). In addition, the number of
somatostatin-expressing cells in both ends, and the number of glicentin-expressing cells in the
proximal end of the ileal remnant decreased after ileal autotransplantation. Thus, our findings
suggest that some transplantation procedure-related factor, presumably extrinsic denervation,
diminishes the enteroendocine cell expression and alters their subtype distribution after
segmental small bowel transplantation in pigs. Furthermore, these changes in the ileal
enteroendocrine cell expression occurred simultaneously with the poor morphological
adaptation. Thus, it is tempting to speculate that the diminished trophic hormone expression
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due to reduced number of enteroendocrine cells, especially glicentin-expressing L-cells, may
partly be responsible for the impaired adaptation of the segmental small bowel graft. However,
as previously discussed, also other factors, such as malnutrition, may explain the poor
morphologic adaptation and reduced enteroendocrine cell expression. Furthermore, ileal villi
were enlarged after denervation and autotransplantation of entire jejunoileum, suggesting
increased enterotrophic hormone expression due to the neural isolation of the small bowel. This
latter finding of our study does not support the above-mentioned speculative explanation about
diminished trophic hormone expression after small bowel transplantation.
BRUSH BORDER DISACCHARIDASES AND THE ENTEROCYTE MATURATION
The specific maltase and sucrase activities (expressed as U/g of mucosal protein) decreased in
the mid-ileum after small bowel resection in pigs (I). However, the total activities of these
disaccharidases (expressed as U/dm2 of serosal area) remained virtually unaltered after
resection compared with the transection group. These findings imply that the growth of the
mucosal structures is able to compensate the defect in the activity of the specific brush border
disaccharidases after small bowel resection. In contrast to the findings after resection, the
specific ileal activities of maltase and sucrase tended to be higher in the autotransplanted ileal
segment, while the total activities of brush border disaccharidases tended to decrease after the
ileal remnant autotransplantation compared with resection (II). Therefore, structural
maladaptation after segmental small bowel autotransplantation in pigs may reduce the brush
border digestive function, and thus inhibit nutrient absorption and impair the weight gain.
Specific (U/g of mucosal protein) and total (U/cm of bowel) disaccharidase activities were
similar in the jejunoileal denervation and in situ autotransplantation groups compared with the
laparotomy and transection groups (IV). Similarly, the specific activity of the brush border
disaccharidases remains unaltered after neural isolation of the jejunoileum in dogs (Sarr et al.
1996). In addition, in the absence of rejection, the initially decreased brush border enzyme
activities are recovered soon after small bowel transplantation (Teitelbaum et al. 1989, Akhtar
et al. 1996). Thus, in conclusion, the small bowel denervation with or without IRI does not
have a significant long-term effect on the brush border enzyme activities.
Impaired enterocyte maturation due to high crypt cell proliferation may explain the decrease in
the activity of the specific brush border enzymes after small bowel resection (Weser and
Hernandez 1971). Enterocyte maturation occurs during the upward migration of the cells along
the crypts and villi. This enterocyte migration is demonstrated to be accelerated by small bowel
resection in rats (Chaves et al. 1987). In addition, at least in mice, enterocyte apoptosis is
increased in the postresectional small bowel mucosa (Helmrath et al. 1998a, Falcone et al.
1999a). Thus, the enterocyte turnover increases, and the life span of individual cells decreases
after small bowel resection, leaving thus less the time for enterocyte maturation. Confusingly,
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we found a decreased density of the villous epithelial cells in the remaining ileum after small
bowel resection, suggesting that the cell size had increased. In contrast, after ileal
autotransplantation the villous epithelial cell density in the ileum was significantly above the
resection group values indicating smaller cells. These findings, together with the changes in the
specific maltase and sucrase activities, suggest that the physical enterocyte size is dissociated
from the functional cellular maturity.
All studies do not support the possibility of functional immaturity of postresectional
enterocytes. Chaves et al. (1987) studied activities of brush border enzymes of enterocytes
using quantitative cytochemistry, and found increased specific α-glucosidase activity after
small bowel resection. This discrepancy between our results and the results of Chaves and
colleagues (1987) may partly be explained by the different methods used to analyze the brush
border enzyme activities. For instance, a large amount of non-epithelial cells in the mucosal
homogenates from which the enzyme activities were measured may have caused bias to our
results (discussed by Falcone et al. 1999b). However, Swaniker et al. (1995) showed increased
activity of specific brush border enzymes after small bowel resection in rabbits using the same
methods as we did. This indicates that other reasons than different analytical methods, such as
differences in the experimental animal species or different timing of the enzyme analyses, are
also involved with the contradictory results concerning specific activity of brush border
enzymes after small bowel resection. Taken together, according to the currently available
reports, it is not clear whether enterocyte maturation is impaired by small bowel resection, as
our results suggest, or whether it remains unaltered or even enhances as an adaptive response to
the resection.
GROWTH HORMONE THERAPY AFTER SMALL BOWEL TRANSPLANTATION
Growth hormone therapy improves body weight gain, increases crypt cell proliferation, and
enhances adaptive small bowel growth after resection in rats (Shulman et al. 1992, Benhamou
et al. 1994, Gomez de Segura et al. 1996). This small bowel adaptation enhancing function of
GH is at least partly mediated via increased IGF-I expression. Administration of IGF-I to rats
with small bowel transplants is shown to improve weight gain, increase mucosal morphometric
characteristics, and enhance nutrient absorption, suggesting that the use of this enterotrophic
growth factor may have beneficial effects on the small bowel graft function (Zhang et al. 1995a
and 1995b). Accordingly, we hypothesized that GH therapy may have beneficial effects on pigs
after small bowel autotransplantation.
Growth hormone therapy enhanced body weight gain after in situ jejunoileal
autotransplantation in pigs compared with untreated animals with similar small bowel
autotransplants. However, GH had virtually no effect on crypt cell proliferation, small bowel
50
morphology, or ultrastructure and maturation (measured by specific disaccharidase activities)
of the enterocytes after small bowel autotransplantation (unpublished data). Growth hormone
treatment has increased amino acid uptake after small bowel resection in rabbits, suggesting
that it may have the capability to enhance enterocyte function (Iannoli et al. 1997). Whether the
enterocyte function of the autotransplanted jejunoileum in pigs improves due to GH therapy is
unknown, but according to our results it seems possible. However, the general anabolic effect
of GH may also explain the improved weight gain observed in GH treated pigs after small
bowel autotransplantation. Furthermore, as a part of combination therapy, GH has increased
body weight gain in patients with SBS (Byrne et al. 1995, Scolapio et al. 1997), but it may
have at least partly occurred due to GH-induced water retention (Ellegård et al. 1997, Scolapio
1999). Whether water retention was the underlying reason for the improved weight gain GH
treated pigs after jejunoileal autotransplantation remains unanswered.
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CONCLUSIONS AND FUTURE PROSPECTS
The studies presented in this thesis extend the current knowledge about the structural
appearance and adaptive ability of the non-rejecting small bowel graft. Our results have clinical
relevance in differentiating the transplantation procedure related alteration of the small bowel
transplant from the changes caused by IRI or immunophenomena. In addition, our findings may
be helpful in clinical cases of small bowel transplantation using segmental grafts from living
related donors. Especially important was the use of porcine models, since the intestines of the
pig are anatomically and physiologically more close to humans than the digestive tract of the
often used rodent models, and perhaps also the widely employed canine models. From the
results presented in this thesis, the following specific conclusions are drawn:
1. Extensive proximal small bowel resection in the growing pig leads to morphologic
adaptation that involves macroscopic and microscopic changes of the remaining small
bowel. These changes predominate in the ileum and occur at least partly as a result of high
crypt cell proliferation. Adaptation-related increase in the mucosal mass compensates the
defect in the specific activity of the brush border disaccharidases of the apparently
functionally immature enterocytes. The number and subtype distribution of the ileal
enteroendocrine cells are not significantly altered by proximal small bowel resection in
pigs.
2. Autotransplantation of the postresectional ileal remnant reduces crypt cell proliferation and
disturbs normal morphologic adaptation of the remaining small bowel in pigs. Poor
adaptation, both in the intact jejunal remnant and in the autotransplanted ileal segment,
suggests a small bowel denervation/IRI-induced systemic factor as the underlying reason
for the impaired adaptation. However, local factors such as bacterial overgrowth may also
be involved. Reduced weight gain after ileal remnant autotransplantation implies that the
adaptive response may be impaired because of malnutrition. However, the absolute and
proportional enteroendocrine cell number, and the number of somatostatin- and glicentin-
expressing cells were unevenly reduced after autotransplantation of the postresectional ileal
remnant. Thus, abnormal hormonal adaptation stimulus due to the changes in the
enteroendocrine cell expression may be involved with the poor morphologic adaptation of
the segmental small bowel graft.
3. Denervation of the entire jejunoileum leads to poor postoperative weight gain in pigs. This
finding is not associated with decreased absorptive surface area, but may be associated with
functional impairments of the individual enterocytes. Denervation-induced changes in the
weight gain or the minor morphological alteration seen mostly in the ileum are not greatly
affected by a synchronous short period of cold ischemia and subsequent reperfusion.
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4. Growth hormone therapy enhances body weight gain after in situ jejunoileal
autotransplantation in pigs, but has no significant effect on the small bowel morphology,
crypt cell proliferation, enterocyte ultrastructure or brush border enzyme expression. These
findings suggest that GH may have positive effects on the absorptive function of the
autotransplanted small bowel. However, general anabolic effects of GH, or other reasons
such as GH induced water retention may also be responsible for the weight gain.
Many questions were raised by the results presented in this thesis. The reason for the poor
weight gain of the animals with denervated or autotransplanted small bowel was considered to
be a consequence of denervation-induced functional impairment of the enterocytes. Further
investigation concerning the ability and timing of the adaptation of the enterocyte function after
transplantation is needed in order to elucidate the prognosis of the small bowel graft function.
The discouraging finding of the poor adaptive ability of the segmental graft in pigs should be
taken into account when considering the clinical use of segmental grafts of living related
donors. Our results suggested that altered enteroendocrine hormone balance may affect
adaptive small bowel growth after transplantation. However, more detailed investigations
concerning small bowel graft adaptation including analyses of gut hormone expression are
needed. Hopefully, future studies will clarify the underlying reason for the disturbed adaptive
ability of the segmental graft, and thus open possibilities, for instance for hormonal therapy to
improve the graft growth after segmental small bowel transplantation. In addition, the positive
preliminary results of enhanced weight gain due to GH treatment after small bowel
autotransplantation require more thorough analysis. Studies should focus on solving the exact
mechanism of increased weight gain during GH treatment and the possibility of using such
therapeutic approach in clinical small bowel transplantation. In final conclusion, reports
concerning results of small bowel transplantation indicate that it is a life-saving treatment for
selected patients with irreversible intestinal failure. However, several problems remain to be
conquered before the small bowel transplantation is considered a routine therapeutic option.
Although immunologic phenomena probably are the most important factors to be studied, many
unknown transplantation procedure related aspects that impair the function of the small bowel
graft also need to be solved.
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CORRECTIONS
Due to calculation error in study I, the originally published villus surface areas on table II are
too small. Corrected values are shown below, in Table 8.
TABLE 8. Villus surface area (mm2)
Biopsy site Preoperative Transection Resection
Proximal jejunum 0.16 ± 0.01 0.26 ± 0.03 # 0.34 ± 0.01 #
Mid-ileum 0.16 ± 0.01 0.29 ± 0.01 # 0.37 ± 0.03 #∗
Distal ileum 0.13 ± 0.02 0.24 ± 0.03 # 0.37 ± 0.03 #∗
Results are expressed as mean ± standard error of the mean. # p < 0.05
vs. Preoperative. ∗ p < 0.05 vs. Transection.
In study II, the mucosal protein contents in Tables 1 and 2 were expressed as mg/g of mucosa,
not as mg/cm2 of serosa.
